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ABSTRACT
Associations between the Adult ADHD Self-Report Rating Scale (ASRS)
and the Test of Differential Inhibition and Attention (TDIA)
A. Benton Darling, M.A.
Attention-Deficit/Hyperactivity Disorder (ADHD) ranks among the most common mental health
disorders in adults (APA, 2013). ADHD assessment is complicated by heterogenous symptoms,
gender and age differences in diagnosis, variability in symptom manifestation across the lifespan,
and comorbidity with other psychiatric disorders and medical conditions (Asherson, 2016;
Willcut, 2012; Williamson & Johnston, 2015). The stop-signal task (SST) identifies ADHD
clinical groups in children and adults (Lifffijt et al., 2005), yet it remains unclear whether SST
performance reflects general deficits in attention (Alderson et al., 2007) or a selective deficit in
motor response inhibition (Aron & Poldrack, 2005). Studies of SST often involve lower
cognitive complexity without the additional inhibitory load produced by interference control
(Uno et al., 2006). Currently, there is no research on SST with interference control in the adult
population. The aim of this study was to assess the diagnostic utility of response inhibition
metrics in the adult population on tasks with greater central processing demands. Forty-nine
adults completed the Adult ADHD Self-Report Scale – V1.1 Symptoms Checklist and the Test
of Differential Inhibition and Attention (TDIA). Results from hierarchical multiple linear
regression analyses showed that TDIA metrics associated with motor response inhibition
significantly predicted self-reported symptoms of inattention, hyperactivity-impulsivity, and
combined ADHD, over and above metrics representing general attention. This study supports the
clinical utility of SST with interference control in identifying ADHD in adults. Furthermore, the
results support a conceptual model of ADHD wherein response control deficits are primary to the
executive dysfunction associated with the disorder. Possible explanations for these results,
limitations of the study, and future directions are explored.
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CHAPTER 1: INTRODUCTION AND REVIEW OF SELECTED LITERATURE
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder
characterized by developmentally inappropriate symptoms of inattention, hyperactivity and
impulsivity. Symptoms of ADHD are pervasive across multiple settings with functional and
developmental impairment in academic, occupational, and social domains (American Psychiatric
Association [APA], 2013). ADHD symptoms may present in childhood, adolescence, or
adulthood and early impairment may persist across the lifespan (APA, 2013; Biederman et al.,
2012).
ADHD was once considered to be solely a childhood disorder with symptoms that
attenuated prior to adulthood (Efron, 2015). Research has since clearly demonstrated that ADHD
symptoms may persist beyond childhood (Biederman, Petty, Evans, Small, & Faraone, 2010;
Guelzow, Loya, & Hinshaw, 2017; Langley et al., 2010). Moreover, there is increasing evidence
for symptom onset during adolescence and adulthood (i.e., after age 12 years), thereby
challenging the notion that ADHD is a childhood disorder (Moffitt et al., 2015). Indeed, ADHD
now ranks among the most common mental health disorders in adults (APA, 2013) with
clinically significant impairment in social, academic, vocational, and neuropsychological
functioning (Klein et al., 2012). ADHD was also once considered to be a disorder of emotional
and behavioral immaturity among prepubescent children (APA, 1968). This antiquated model
has since been supplanted by a modern conceptualization based on cognitive and executive
dysfunction (Barkley, 1997; Douglas, 1972).
As our understanding of the etiology and pathology of ADHD continues to evolve, there
is increasing need for diagnostic tools that reflect these scientific advancements. ADHD
assessment is complicated by a variety of factors including heterogeneity in symptoms, gender
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and age differences in rates of diagnosis, variability in symptom manifestation across the
lifespan, and high comorbidity with other psychiatric disorders and medical conditions
(Asherson, 2016; Willcut, 2012; Williamson & Johnston, 2015). Additionally, ADHD is
associated with deficits in academic, social, occupational, and emotional functioning, making it
difficult to differentiate ADHD from other psychiatric disorders (Bruner, Kuryluk, & Whitton,
2015; Klein et al., 2012; Prevatt & Young, 2014; Skirrow & Asherson, 2013).
Identifying ADHD in adults is a particularly challenging clinical endeavor, especially
with individuals whose symptoms present during adolescence or adulthood (Agnew-Blais et al.,
2016; Caye et al., 2016; Moffitt et al., 2015). Because current diagnostic criteria require a history
of childhood onset and impairment (APA, 2013), assessment methods with adult patients often
involve retrospective self- and collateral-report of symptoms, which are known to have limited
validity and reliability (Sibley et al., 2012). Furthermore, there may be no childhood impairment
for individuals whose symptoms first present in adulthood (Moffitt et al., 2015), thus our current
diagnostic criteria may be too restrictive to accurately capture the nature of ADHD in some
cases. Potential secondary gains such as access to ADHD medication and eligibility for social
and academic services for individuals diagnosed with ADHD add complexity to the assessment
process (Leppma, Long, Smith, & Lassiter, 2017). Finally, symptom manifestation may vary in
adulthood as a function of self-selected environments, thereby creating context-specific
impairment (Lasky et al., 2016). Individuals may pursue activities and environments that
minimize their perceptions of impairment, thereby masking more global deficits associated with
ADHD (Mordre, Groholt, Sandstad, & Myhre, 2012).
Because of these challenges, it behooves diagnosticians to develop instruments that can
validly and reliably identify ADHD while differentiating affected individuals from other clinical
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and non-clinical populations. The stop-signal task (SST) is useful in identifying ADHD and nonADHD groups (Alderson, Rapport, & Kofler, 2007; Aron, Dowson, Sahakian, & Robbins, 2003;
Lijffijt, Kenemans, Verbaten, & van Engeland, 2005; Oosterlaan, Logan, & Sergeant, 1998;
Wodushek & Neumann, 2003), and yet the reason for its utility remains an area of scholarly
debate. A segment of the cognitive psychology community points to inefficient processing due to
generalized attention deficit as the predominate feature of individuals with ADHD compared to
controls (Alderson et al., 2007; Castellanos & Tannock, 2002; Epstein et al., 2010; Lifffijt et al.,
2005; Oosterlaan et al., 1998). Conversely, many researchers have highlighted cognitive control
deficits associated with motor response inhibition as a core feature of ADHD, with stop-signal
inhibition being proposed as a key endophenotype (Aron et al., 2003; Aron & Poldrack, 2005;
Berger & Cassuto, 2014; Hart et al., 2014; Kofler et al., 2013; McAuley, Crosbie, Charach, &
Schachar, 2013; Schachar et al., 2005; Wodushek & Neumann, 2003). The emphasis on a
general deficit in cognitive control versus a selective deficit in response inhibition varies across
studies of SST, the majority of which involve tasks of lower cognitive complexity without the
additional inhibitory load introduced by interference control (Uno et al., 2006; van Velzen,
Vriend, de Witt, & van den Heuvel, 2014). Absent from the SST literature is assessment of the
diagnostic utility of response inhibition metrics in the adult population on tasks with greater
central processing demands produced by interference control.
In this study, I take an initial step toward clarifying the clinical utility of response
inhibition metrics in the assessment of ADHD in adulthood. I preliminarily assessed the clinical
utility of a newly developed measure of attentional processing and response control by
examining performances in a sample of clinical and non-clinical adults (i.e., 18 years of age or
older). The purpose of the study is to advance the development of a new diagnostic tool while
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evidencing response inhibition deficits in individuals with ADHD based on stopping latencies in
the stop-signal paradigm.
Review of Selected Literature
Prevalence
ADHD is generally considered a disorder of childhood with prepubescent onset (APA, 2013). A
report by the National Institute of Mental Health (NIMH; 2017) showed that the median age of
symptom onset for children was six years. ADHD ranks among the most prevalent mental health
disorders in children and adolescents in the United States (NIMH, 2010) and is associated with
national economic costs estimated between $143 and $676 billion (Doshi et al., 2012). The
average cost of raising a child with ADHD is estimated at $15,000 (before treatment expenses),
more than five times the average amount spent by neurotypical families (Zhao et al., 2019). In
the study, parents and caregivers of participants with ADHD often experienced indirect costs
related to inconsistent employment and lower work efficiency.
Assessments of national trends revealed increases in diagnoses by 66% from 2000 to
2010 (Garfield et al., 2012), by 42% from 2003 to 2011 (NIMH, 2017), and by 31% between
2010 and 2017 (Blue Cross Blue Shield Association, 2019). It is estimated that the current
worldwide prevalence of ADHD in childhood ranges from 5% (Asherson, 2016) to 7.2%
(Thomas, Sanders, Doust, Beller, & Glasziou, 2015) and from 2.5–4.4% in adulthood (APA,
2013; NIMH, 2017), ranking it among the most common psychiatric conditions among children
(NIMH, 2010) and adults (APA, 2013).
Subtypes and Symptoms
ADHD is heterogeneous in clinical presentation as evidenced by three subsyndromal types:
predominantly inattentive, predominantly hyperactive/impulsive, and combined presentation
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(APA, 2013). The predominantly inattentive presentation is characterized by difficulty with
sustained attention, task completion, and organization, as well as forgetfulness and distractibility.
The predominantly hyperactive/impulsive type is marked by excessive motor activity or talking,
action without forethought, restlessness, difficulty with turn-taking, and interruption of or
intrusion on others. The combined designation is reserved for individuals who exhibit symptoms
of both inattention and hyperactivity/impulsivity. Data drawn from meta-analytic studies show
that the predominantly inattentive presentation is most common in the general population;
however, individuals with the combined presentation are most likely to be referred for clinical
services (Willcutt, 2012).
Gender Differences
Males are diagnosed with ADHD at a higher rate than females for all disorder subtypes
(Willcut, 2012). Estimates range from 3-4:1 (Magnin & Maurs, 2017) to 9:1 (Bruchmuller,
Margaf, & Schneider, 2012) in the clinical population, including 10:1 among children,
specifically (Williamson & Johnston, 2015). Scholars have attributed this discrepancy to social
processes such as methodological inconsistency (Williamson & Johnston, 2015) and systematic
referral bias related to social expectations for behavior in boys and girls (Biederman et al., 2005).
In one study, a sample of 1,000 mental health professionals read male and female versions of an
otherwise identical case vignette and were asked to render or withhold a diagnosis. The male
version resulted in a diagnosis of ADHD in about twice the number of cases compared to the
female vignette (Bruchmuller et al., 2012). The authors posited that a representative heuristic led
participants to view the male subjects as more prototypical of ADHD children. Other scholars
have disagreed with this conclusion, suggesting that the discrepancy is due to genuine etiological
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differences in genetic and cognitive liabilities that persist after controlling for selection bias
(Arnett, Pennington, Willcutt, DeFries, & Olson, 2015).
Age Differences
Age differences may also be emblematic of subjectivity in diagnosis. Elder (2010)
demonstrated that ADHD diagnoses were not based solely on underlying neurological
conditions; instead, rates of diagnosis varied systematically depending on children’s ages relative
to eligibility cutoffs for admittance to kindergarten in their states. Elder (2010) found that the
youngest children were more than twice as likely to be diagnosed with ADHD compared to the
oldest children in each grade. Younger children were also more than twice as likely to be treated
using psychostimulant medication. These results suggest that the relative immaturity of younger
schoolchildren may lead to disproportionately higher rates of ADHD diagnoses and subsequent
pharmacological intervention.
Evans, Morrill, and Parente (2010) replicated Elder’s (2010) findings using data collected
from 1996 through 2006 by three national health organizations. Their results indicated that
children who were older for their grade were less frequently diagnosed with and treated for
ADHD compared to younger children. Both Elder (2010) and Evans et al. (2010) attributed their
results, in part, to differences in maturity levels between younger and older children. Data
collected from 2007 through 2015 showed similar trends, with significantly higher rates of
diagnosis and treatment of ADHD among children born in August than among children born in
September in U.S. states with a September 1 cutoff date for kindergarten admission (Layton,
Barnett, Hicks, & Jena, 2018).
Elder and Lubotsky (2009) suggested that younger children are more likely to exhibit
emotional, educational, and behavioral deficits that are characteristic of ADHD endophenotypes
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compared to older children in the same grade. APA (2013) noted that symptom identification in
young children is complicated by high variability in normative behavior. Elder and Lubotsky
(2009) added that developmental discrepancies may contribute to over-diagnosis of ADHD
among young children whose symptoms are conflated by relative immaturity in comparison with
same-grade peers. Meanwhile, older children may be underdiagnosed because their symptoms
may be less obvious amid their younger, possibly less mature classmates. Elder and Lubotsky
(2009) concluded that diagnosticians must consider symptom profiles relative to same-age rather
than same-grade peers.
Etiology and Risk Factors
Presently there is no known single etiology for ADHD (Magnin & Maurs, 2017), though
biological and environmental determinants have been implicated. Twin studies suggest that
genetic heritability is between 60% and 90% (Faraone & Mick, 2010; Spencer, Biederman,
Wilens, & Faraone, 2002; Waldman & Gizer, 2006), with a mean heritability estimated at 75%
worldwide (Beiderman & Faraone, 2005; Faraone et al., 2005). A recent genome-wide
association meta-analysis of 20,183 individuals diagnosed with ADHD revealed 12 genomic
regions where people with ADHD differed from controls (Demontis et al., 2019). The
researchers suggested that this genetic profile contributes about 22% of the risk of developing
ADHD.
Contributions from social or environmental factors are also implicated, with estimates
ranging from 10% to 40% (Waldman & Gizer, 2006). For example, the basal ganglia are linked
to ADHD for their role in motor response inhibition (Guo, Schmitz, Mur, Ferreir, & Anderson,
2018; Shaw et al., 2014). The basal ganglia are a collection of subcortical structures in the
telencephalon that includes the caudate nucleus, the putamen, and the globus pallidus. These
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structures collectively facilitate or inhibit movement through interaction with the motor cortex.
The basal ganglia are known to be particularly vulnerable to hypoxia (Froehlich et al., 2011).
Additionally, early exposure to technologies (e.g., television) is associated with deficits in
attentional functioning among children (Christakis, Zimmerman, DiGiuseppe, & McCarty, 2004;
Tamama et al., 2019). Thus, the combination of biological and environmental determinants is
cause for scholarly consensus that the etiology of ADHD is polygenetic and multifactorial
(Magnin & Maurs, 2017; van Ewijk & Oosterlaan, 2015; Waldman & Gizer, 2006).
Pathophysiology
The prefrontal cortex (PFC) has consistently been the predominant focus in ADHD
research given its association with executive functions (Arnsten, 2009). The PFC is critical in
regulating and sustaining attention, screening distractions, inhibiting emotional and behavioral
impulses, planning, organizing, and facilitating working memory (Arnsten, 2009; Spencer,
Biederman, & Mick, 2007). Specific regions within the PFC are linked to particular executive
functions. The dorsolateral PFC is associated with organization, planning, working memory, and
attention (Bush, Valera, & Seidman, 2005). The inferior frontal gyrus of the ventrolateral PFC is
associated with response inhibition as damage to this region was shown to elicit delays in
response suppression on measures of attention and response control (Aron, Fletcher, Bullmore,
Sahakian, & Robbins, 2003). Dysfunction in the orbitofrontal cortex is also indicated in ADHD
research for its association with behavioral inhibition and impulse control (Seidman, Valera, &
Makris, 2005).
PFC functioning is contingent on the concentration of two primary catecholamines,
dopamine (DA) and norepinephrine (NE), and small changes in the levels of these
neurotransmitters have immense effects on executive functioning (Arnsten, 2009). The dopamine
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hypothesis of ADHD suggests that deficits in tonic DA in the synaptic cleft are responsible for
ADHD symptoms (Levy, 1991). Because the PFC is especially rich in DA (Spencer et al., 2007),
dysfunction of the DA system in the nigrostriatal, mesolimbic, and mesocortical pathways is
believed to account, at least partially, for PFC underactivity that underlies ADHD (Genro,
Kieling, Rohde, & Hutz, 2010). These pathways connect the PFC to midbrain structures
including the hippocampus, amygdala, substantia nigra, ventral tegmental area, striatum, and
nucleus accumbens (Meyer & Quenzer, 2013). NE at high levels is also associated with PFC
dysfunction. Stimulation of NE receptors enhances and prolongs the functioning of neural
connections responsible for attention, behavior, and emotion regulation. Blocking NE receptors
is associated with hyperactivity and impulsivity (Arnsten, 2009; Arnsten & Li, 2005).
Associations between DA, NE, and ADHD have led to the development of
pharmacotherapies that specifically target DA and NE systems in the PFC (Genro et al., 2010).
Two common psychostimulants, methylphenidate and amphetamine, enhance neurotransmission
of DA and NE by inhibiting reuptake of DA and NE through inhibition of dopamine transporter
proteins (DAT) and norepinephrine transporters proteins (NET), respectively. Amphetamine
exerts an additional effect by stimulating the release of DA and NE at the synapse (Pliszka,
2005). When uninhibited, DAT and NET function to inactivate DA and NE through reuptake by
moving the neurotransmitters from the synaptic cleft into nerve terminals. By inhibiting the
membrane transporter proteins responsible for reuptake, synaptic neurotransmitter levels
increase. Once amphetamine enters the nerve terminal, it stimulates endogenous DA release into
the extracellular fluid, resulting in an increase in synaptic DA levels (Meyer & Quenzer, 2013).
The etiological role of candidate genes within these neurotransmitter systems has been
examined in molecular genetics and functional imaging studies of ADHD (Arnsten, 2009; Genro
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et al., 2010). Genes within the dopaminergic pathway are robustly implicated as primary
contributors to the etiology and pathophysiology of ADHD due to their important role in
regulating attention (Ptacek, Kuzelova, & Stefano, 2011). These include the dopamine
transporter gene (DAT1; chromosomal location 5p15.33) and receptor genes (DRD3, DRD4, and
DRD5; chromosomal location 3q13.31, 11p15.5, and 4p16.1, respectively) (Gizer, Ficks, &
Waldman, 2009; Waldman & Gizer, 2006). The candidate gene most widely connected with
disorders of attention is the 7-repeat allele of the DRD4 receptor gene (Spencer et al., 2002).
The Attentional System
In their seminal article, Posner and Petersen (1990) identified three separable, yet
integrated networks within the attentional system of the human brain: alerting, orienting, and
executive control. Exploration of these networks has proven useful in identifying motor response
inhibition as a prominent ADHD endophenotype (Hart et al., 2014; McAuley et al., 2013).
Peterson and Posner (2012) later updated this model considering 20 years of subsequent
cognitive neuroscience research using brain imaging technology. The following is an overview
of their updated model of the attentional system of the human brain.
First, the alerting network is involved in shifting between states of tonic and phasic
alertness. Tonic alertness refers to an idle or “ready state” of intrinsic arousal. In contrast, phasic
alertness refers to a rapid shift in arousal triggered by an environmental event that, like a warning
signal, prepares the attentional system for signal detection and response execution (DeGutis &
Van Vleet, 2010). The mediation of arousal involves the ascending reticular activating system,
which is initiated by NE release in midbrain structures such as locus coeruleus projections and
superior colliculus (Aston-Jones & Cohen, 2005). Activation of this system occurs in response to
a cue that indicates an upcoming target stimulus (Peterson & Posner, 2012).
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Second, signal detection is performed by the orienting system wherein sensory input,
such as spatial cues, are processed. The orienting system is comprised of two sensory processing
networks, the ventral attention network (VAN) and dorsal attention network (DAN). VAN is a
bottom-up processing network used to orient to sensory stimuli outside of direct attention, or
exogenous attention. Bottom-up processing refers to perceiving exogenous sensory information,
allowing the stimulus to influence our perceptions or cognitive awareness in a data-driven
manner. VAN is right lateralized in the temporoparietal junction and the ventral frontal cortex.
Conversely, DAN uses top-down visuospatial processing to orient to expected presentations of
stimuli based on a given task or event. Top-down processing involves the use of background or
contextual knowledge to inform our perception of a stimulus. DAN involves exogenous and
endogenous attention and is comprised of the frontal eye fields and the intraparietal
sulcus/superior parietal lobe (Davidson & Marrocco, 2000).
Finally, the executive control system involves two control networks, the frontoparietal
network (FPN) and cingulo-opercular network (CO) (Dosenbach, Fair, Cohen, Schlaggar, &
Petersen, 2008). The FPN includes the dorsal frontal cortex, dorsolateral prefrontal cortex,
inferior parietal lobule, and inferior parietal sulcus. It is associated with cognitive flexibility
required to switch between cognitive tasks (Rossi, Bichot, Desimone, & Ungerleider, 2007). The
CO is comprised of the anterior prefrontal cortex, anterior insula/operculum, dorsal anterior
cingulate cortex, and thalamus. It is associated with set maintenance across task trials
(Dosenbach et al., 2008).
Our efforts to understand the characteristics of ADHD are inextricably linked to the work
of Posner and Petersen (1990). Identification of the networks within the human attentional
system has resulted in advanced understanding of the neural components involved in motor
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response inhibition. The right and left frontal gyri have been identified as key structures in
successful inhibitory control (Aron et al., 2003; Swick, Ashley, & Turken, 2008). Functional
connectivity research by Dambacher et al. (2013) suggests that specific response inhibition
networks may be activated in a task-dependent manner. Their analysis revealed that tasks
involving action restraint resulted in activation of the right superior frontal gyrus, left middle
frontal gyrus, and the bilateral anterior cingulate cortex, while action cancellation tasks yielded
activation of the right middle frontal gyrus, posterior cingulate cortex, and parietal regions.
Cognitive flexibility, also known as task-switching or alternating attention, has also been
predicted by activation of specific brain regions using fMRI. Pretrial neural activity in the basal
ganglia, anterior cingulate cortex, prefrontal cortex, and posterior parietal cortex predicted
subsequent cognitive flexibility during a task-switching procedure (Leber, Turk-Browne, &
Chun, 2008).
Taken together, the human attentional system involves multiple components (i.e., the
alerting, orienting, and executive control systems), thus attention does not represent a single,
unitary construct. Rather, it is a process in which each individual network plays a unique role in
identifying when, where, and how the attentional system will function. Additionally,
advancements in cognitive neuroscience research have revealed distinct neural mechanisms
underlying the cognitive control deficits that are associated with ADHD, highlighted by
activation of multiple structures within the cortico-striatal-thalamic-cortical loop (Castellanos,
Sonuga-Barke, Milham, & Tannock, 2006). These advancements prompted efforts among
scholars to develop and evaluate measures of motor response inhibition, such as SST.
History of the Taxon
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The current understanding of ADHD as a childhood disorder is rooted in clinical
nomenclature from the 20th century (Efron, 2015). Labels used to describe the disorder now
called ADHD have undergone multiple iterations, all of which emphasize childhood impairment.
The taxonomy evolved from hyperkinetic reaction of childhood (APA, 1968), hyperactive child
syndrome (Wood, Reimherr, Wender, & Johnson, 1976), and attention deficit disorder (APA,
1980) to the current classification introduced by the APA in 1994 (APA, 1994).
Hyperkinetic reaction of childhood (APA, 1968) attributed children’s symptoms to stress
reactions to stimuli within the family environment (Mallet, Natarajan, & Hoy, 2014; McGough
& McCracken, 2006). This attribution yielded a conceptualization of ADHD as a childhood
disorder with hyperactivity caused by emotionally or behaviorally immature reactions to
stressors. Impairment was therefore expected to diminish concurrent with normative maturation
during puberty.
Scholars soon challenged the notion that children outgrow hyperactivity with greater
emotional or behavioral maturity. For instance, Wood et al. (1976) acknowledged that
hyperactive child syndrome presents in childhood yet disagreed that impairment attenuates in
adolescence. Instead, they suggested symptoms are transformed in adolescence and adulthood
with impairment marked by greater inattention and impulsivity in addition to continued
hyperactivity. Asherson (2016) added that emotional instability remains a core presentation for
individuals with ADHD, though it is possibly a product of other impairments. Wood and
colleagues (1976) posited that the emergence of inattentiveness does not necessarily supplant
hyperactivity nor signify the conclusion of a childhood disorder. They added that other
diagnostic labels (e.g., hysteria) may conceal what is more accurately conceptualized as
persistent symptoms of childhood hyperkinesis in adulthood.
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Our understanding of etiology changed most markedly with the work of Douglas (1972)
and Barkley (1997) who shifted the conversation away from emotional and behavioral
immaturity in the direction of executive dysfunction. First, Douglas (1972) emphasized
attentional and impulse control deficits as core features of ADHD. Barkley (1997) later proposed
a self-regulation model with five major executive impairments that contribute to the deficits
associated with ADHD: response inhibition, working memory, self-regulation of emotion and
motivation, and reconstitution. At the core of Barkley’s (1997) model was impairment in
response inhibition that was unique to ADHD. All other impairments were secondary as their
function was contingent on effective and efficient response inhibition. Barkley’s (1997) model
was a catalyst for viewing ADHD as a disorder of executive functioning, which is known to play
an important role in self-regulatory and goal-directed behavior (Pennington & Ozonoff, 1996).
Barkley’s (1997) model postulates that the behavior of individuals with ADHD is highly
regulated by their immediate environment compared to healthy controls.
The APA (1980) paralleled this advancement by introducing the term, attention deficit
disorder, to classify a profile of symptoms which emphasized deficits in executive control in
accordance with Douglas’s (1972) and Barkley’s (1997) models. Indeed, numerous studies have
since identified a variety of executive functioning deficits in ADHD such as behavioral
inhibition (Alderson et al., 2007; Nigg, 2001; Van Mourik, Oosterlaan, & Sergeant, 2005),
working memory (Martinussen, Hayden, Hogg-Johnson, & Tannock, 2005; Rapport, Chung,
Shore, & Isaacs, 2001), strategic planning (Kofman, Larson, & Mstofsky, 2008), and sustained
attention and vigilance (Egeland, Johansen, & Ueland, 2009).
Subsequently, clinical research evidenced symptom onset and persistence in adolescence
(Biederman et al., 2012), which prompted the APA to revise its diagnostic criteria in response to
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burgeoning support for greater longevity of the disorder (APA, 1987). Still, APA (1987; 1994)
included an age-of-onset criterion of seven years, signifying developmental onset. Barkley and
Biederman (1997) contended that the arbitrary selection of seven years did not withstand
empirical nor conceptual scrutiny either for onset of symptoms or impairment. These scholars
articulated their rationale, noting that the criterion was “scientifically indefensible, poses
unwarranted practical problems for the study of older adolescents and adults, and may be
arbitrarily discriminatory” (p. 1204). Most recently, the age of onset criterion was revised from
seven to 12 years with the publication of the Diagnostic and Statistical Manual of Mental
Disorders – Fifth Edition (DSM-5; APA, 2013), extending the period during which symptom
impairment may present by five years.
Diagnostic Criteria
The DSM-5 (APA, 2013) enumerates diagnostic criteria for ADHD consisting of 18
symptoms of inattention, hyperactivity, and impulsivity. Diagnostic thresholds are determined by
the severity of clinical impairment as symptoms of ADHD are continuously distributed
throughout the population (Asherson, 2016). A diagnosis under the current system requires the
presence of several symptoms of inattention and/or hyperactivity/impulsivity before the age of
12 years (APA, 2013). Examples include “has difficulty remaining focused during lectures,
conversations, or lengthy reading” and “often forgetful in daily activities [such as] running
errands…returning calls, paying bills, keeping appointments” (APA, 2013, p. 59). The age-ofonset criterion of 12 years exemplifies a present understanding of ADHD as a
neurodevelopmental disorder with symptom onset in childhood. The DSM-5 states, “ADHD
begins in childhood” (APA, 2013, p. 61); therefore, there is no recognition of ADHD onset
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beyond age 12 years. Without a history of impairment in childhood, there can be no diagnosis of
ADHD (Craig, 2011).
Scholars debate the validity of the age criterion citing symptom onset versus persistence
in adolescence and adulthood (Agnew-Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015).
To some, ADHD is a lifelong condition (Magnin & Maurs, 2017); to others, ADHD can be a
disorder solely of adulthood for some patients (Moffitt et al., 2015).
ADHD in Adolescence and Adulthood
Persistence. Although the prevailing notion for several decades was that ADHD was a
neurodevelopmental disorder solely of childhood (Spencer et al., 2007), it is now estimated that
about 2.5–4% of adults meet diagnostic criteria for ADHD (APA, 2013; Fayad et al., 2007),
ranking it among the most common psychiatric conditions in adulthood (APA, 2013). The
possibility that childhood ADHD symptoms may persist into adolescence and adulthood was first
questioned by Wood et al. (1976) and officially recognized for the first time by the APA in 1987
(APA, 1987).
Research on ADHD in adults is relatively new, with greater than 75% of the literature
published within the past 10 years (Williamson & Johnson, 2015). Though still in its infancy, a
burgeoning literature supports the potential for symptom persistence beyond childhood
(Biederman et al., 2010; Biederman et al., 2012; Klein et al., 2012; Langley et al., 2010). While
ADHD is known to affect adult patients (Balint, Czobor, Komlosi, & Meszaros, 2009; Wilens et
al., 2009), inconsistent research findings make it difficult to achieve consensus regarding
persistence rates. One explanation for the variability is methodological and definitional
inconsistency across studies, particularly the diagnostic criteria used in assessment (Magnin &
Maurs, 2017; Spencer et al., 2007). For example, comparing rates of diagnosis among adults
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using former (APA, 1994) and current (APA, 2013) criteria resulted in a 27% increase in
prevalence estimates in one study (Matte et al., 2015) and 65% in another (Rigler et al., 2016).
These figures may be associated with a more inclusive age-of-onset criterion of 12 years. Rigler
et al. (2016) also noted that fewer symptoms are required for a diagnosis of ADHD under the
current system, thereby lowering the diagnostic threshold.
Some studies have reported relatively low persistence rates ranging from 4% (Mannuzza,
Klein, Bessler, Malloy, & LaPadula, 1998) to 22% (Klein et al., 2012). Comparatively, a
longitudinal study revealed that clinically significant childhood symptoms were retained in
young adulthood in 58% of cases (Barkley, Fischer, Smallish, & Fletcher, 2004). Subsequent
research showed that 70% of diagnosed children (mean age of 9.4 years) continued to meet full
criteria for ADHD five years later in adolescence (Langley et al., 2010). Similar results were
reported by Biederman et al. (2012) who observed either full or subthreshold symptom
persistence in 77% of childhood cases at 10- to 16-year follow-up during adolescence.
The persistence of symptoms beyond childhood occurs at comparable rates for boys and
girls. Results of a 10-year longitudinal study demonstrated that about 35% of diagnosed boys
continued to meet diagnostic criteria in adulthood (Biederman et al., 2010). Likewise, a 10-year
follow-up study of girls revealed that 44% met full criteria as adults (Guelzow et al., 2017).
Although boys are diagnosed with ADHD at a higher rate than girls (Magnin & Maurs, 2017),
based on these findings, both are comparably susceptible to persistent functional impairment
throughout the lifespan. The degree of impairment has been shown to vary by gender, however,
with males displaying a higher level of neurocognitive deficits as adults compared to females
(Balint et al., 2009).

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

18

Data from meta-analytic studies suggest that an estimated 50% of adults remain impaired
by persistent childhood symptoms that are detrimental to daily functioning, even when their
symptoms are in partial remission or are subthreshold diagnostically (Faraone, Biederman, &
Mick, 2006). A 16-year controlled, longitudinal study by Biederman et al. (2012) showed that
adult ADHD is associated with greater psychosocial, educational, and neuropsychological
impairment compared to age- and sex-matched controls. Symptom persistence has been
associated with a greater number of childhood symptoms and lower childhood IQ (Agnew-Blais
et al., 2016), as well as childhood symptom severity and treatment history (Caye et al., 2016).
Despite overall variability in persistence rates, the potential for ADHD symptoms to be retained
in adolescence and adulthood is well-established in the literature.
Onset. Research is also increasingly supporting the possibility of symptom onset beyond
childhood, at ages ranging from 13 to 38 years (Agnew-Blais et al., 2016; Caye et al., 2016;
Moffitt et al., 2015). In a nationally representative four-decade longitudinal cohort study, Moffitt
et al. (2015) found that 90% of adults with diagnosable ADHD did not experience clinically
significant impairment in childhood; importantly, all DSM-5 (APA, 2013) criteria were met
except for onset-age prior to 12 years. Based on this sample, Moffitt and colleagues (2015)
questioned whether ADHD is in fact a childhood-onset neurodevelopmental disorder. Their data
suggest that ADHD symptom onset may also occur after the age of 12 years. Another study
found that adults with ADHD symptoms experience comparable levels of impairment, regardless
of age-of-onset (Agnew-Blais et al., 2016). The researchers found few discernable differences
between individuals with persistent and late-onset ADHD, suggesting that adult impairment is
similar for individuals whose symptoms presented before or after age 12 years. This literature
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provides initial support for continued revision, if not elimination, of the onset-age criterion of 12
years in the DSM-5 (APA, 2013).
Not all studies report equally high prevalence rates for adult-onset ADHD, however, nor
do they report equal levels of impairment between childhood- and adult-onset ADHD. For
example, in a sample of 388 adult outpatients, only 6.9% were classified as having adult-onset
ADHD with symptoms that were less severe than patients with childhood-onset (Lopez,
Micoulaud-Franchi, Galera, & Dauvilliers, 2017). Despite some evidence to the contrary, overall
the literature suggests that clinically significant symptoms may not present until adolescence or
young adulthood for some individuals.
Course. Current and recent literature suggests a high degree of variability in symptom
manifestation across the lifespan (Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004;
Williamson & Johnston, 2015). Early childhood symptoms often manifest as excessive motor
activity, such as running and climbing, yet children often experience a marked decline in motor
hyperactivity during adolescence. Hyperactive symptoms often remit earlier in the lifespan than
do inattentional effects, which become more prominent during adolescence and early adulthood
(APA, 2013; Asherson, 2016; Biederman, Mick, & Faraone, 2000). Adults may still experience
hyperactivity or impulsivity, but what previously manifested as excessive running and climbing,
for example, may later present as fidgeting, impatience, or restlessness (Craig, 2011).
Differences in symptom manifestation between children and adults may not be fully
attributable to epidemiological factors. Manifestations of adult ADHD may be subjectively and
contextually influenced by sociocultural variables such as academic or occupational activities
that emphasize certain functional capacities more than others (Sibley, Mitchell, & Becker, 2016).
Some adults with ADHD describe their impairment as context-specific, citing symptoms that are
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strengths in one setting and liabilities in another (Lasky et al., 2016). Selection of environments
that magnify attentional deficits and minimize hyperactivity or impulsivity, for example, may
lead to an erroneous conclusion that inattention remits more slowly. It is also possible that
hyperactive symptoms are equally present but do not produce the same level of functional
impairment in their respective contexts due to specific environmental demands (Lasky et al.,
2016) or increased use of adaptive coping mechanisms (Jensen et al., 1997). There is therefore an
interaction effect between individuals and their environments that contributes to variability in
impairment across the lifespan (Lasky et al., 2016).
Comorbidity and Deleterious Outcomes. Diagnosing ADHD is complicated by a high
degree of overlap in functional impairment with a variety of neurodevelopmental and psychiatric
disorders (Anastopolous et al., 2018; Asherson, 2016; Cadman et al., 2016). A four-year followup study of diagnosed children found elevated risk for other mental health conditions including
anxiety and mood disorders, deficient intellectual and academic functioning, and conduct
problems (Biederman et al., 1996). A second longitudinal study followed diagnosed children into
adulthood and found that hyperactive youth were at greater risk for conduct problems (e.g.,
property theft, assault) and illegal drug-related activity than community controls (Barkley et al.,
2004). Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) are often comorbid
with ADHD, with estimates of dual diagnoses around 60% and 40%, respectively (Connor,
Steeber, & McBurnett, 2010). Several studies have also reported increased risk of substance use
disorders among ADHD patients (Estevez et al., 2016; Young et al., 2015) with twice the
population rate among clinical samples (Asherson, 2016). Children with ADHD were found to
be three times more likely to use nicotine or marijuana in their lifetime than individuals without
ADHD (Lee, Humphreys, Flory, Liu, & Glass, 2011). Childhood ADHD has also been shown to
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predict earlier onset and higher rates of risky sexual behavior in young adulthood (Flory, Molina,
Pelham, Gnagy, & Smith, 2006).
ADHD is also related to greater emotional dysregulation (Lenzi, Cortese, Harris, & Masi,
2018; Skirrow & Asherson, 2013), feelings of loneliness (Stickley, Koyanagi, Takahashi,
Ruchkin, & Kamio, 2017), depression (Bron et al., 2016; Michielsen et al., 2013; Simon,
Czobor, & Bitter, 2013), and suicidality (Stickley, Koyanagi, Ruchkin, & Kamio, 2016).
Individuals with ADHD may be at greater risk for prolonged mood dysregulation as evidenced
by findings that ADHD is associated with increased treatment resistance to antidepressant
medication (Chen et al., 2016).
Higher rates of antisocial personality disorder have been reported for samples of ADHD
patients (Biederman et al., 2004; Klein et al., 2012). Research has also associated ADHD with
medical conditions including obesity (Nigg et al., 2016), bulimia nervosa (Ziobrowski,
Brewerton, & Duncan, 2018) and other disordered eating behaviors (Bleck & DeBate, 2013;
Kaisari, Dourish, & Higgs, 2017; Levin & Rawana, 2016), celiac disease (Instanes, Klungsoyr,
Halmou, Fasmer, & Haavik, 2018), and premature death (Dalsagaard, Ostergaard, Leckman,
Mortensen, & Pedersen, 2015; London & Landes, 2016). ADHD has been associated with
neurodevelopmental disorders including autism spectrum disorder (Gillberg et al., 2004) and
specific learning disorder (Sexton, Gelhorn, Bell, & Classi, 2012).
In addition to comorbid medical and mental health concerns, individuals with ADHD
often experience greater social, occupational, and vocational dysfunction (Spencer et al., 2002).
ADHD is associated with a variety of poorer outcomes in academic, emotional, social, and legal
domains among adolescents (Spencer et al., 2007). Symptoms in adulthood have been associated
with lower socioeconomic status (Borland & Heckman, 1976), as well as greater prevalence of
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psychological maladjustment, traffic offenses, disruptions in employment, and divorce (Murphy
& Barkley, 1996).
In a 33-year longitudinal assessment of clinical and functional outcomes of childhood
ADHD, Klein et al. (2012) reported relative dysfunction among probands in educational,
occupational, economic, and social domains compared to unaffected peers. The clinical sample
had 2.5 fewer years of education on average with significantly lower occupational attainment and
median annual salary, and significantly higher rates of divorce. Individuals with ADHD also
showed higher rates of incarceration, psychiatric hospitalization, and mortality. Bruner and
colleagues (2015) corroborated these results by finding diminished social functioning via
impaired relationship quality in young adults with ADHD.
Kessler et al. (2006) demonstrated that adult ADHD was associated with greater rates of
disability on all three dimensions of basic functioning as assessed by the World Health
Organization’s Disability Schedule: self-care, mobility, and cognition. They also noted deficits in
instrumental functioning including days out of role, productive role functioning, and social role
functioning. Finally, research has also indicated poorer academic performance (Prevatt & Young,
2014) and higher prevalence of learning disorders (DuPaul, Gormley, & Laracy, 2013) among
individuals with ADHD.
The literature is clear that persistent childhood ADHD symptoms are associated with a
myriad of far-reaching and deleterious outcomes. Comorbidity among ADHD and other
psychiatric or medical conditions presents a formidable challenge to diagnosticians. For
instruments to be effective, they must aid clinicians in differentiating ADHD from other
disorders. Importantly, functional impairment associated with ADHD has been shown to exert
itself independently from concurrent mental health problems. The neuropsychological (Faraone
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et al., 2000), psychosocial, educational, occupational, and cognitive impairment (Biederman et
al., 2012) linked to ADHD symptoms have been shown to persist after statistically controlling
for comorbid psychiatric conditions. Comprehensive and accurate assessment is therefore critical
for identifying ADHD in clinical presentations with high comorbidity.
Assessment and Diagnosis of Adult ADHD
Accurate assessment and diagnosis of ADHD in adulthood is a challenging clinical
endeavor due to heterogeneous and ambiguous symptoms (Uno et al., 2006), variability in
functional impairment (Spencer et al., 2007), presence of comorbid disorders (Faraone et al.,
2000), and use of instruments that were intended to diagnose ADHD in children and adolescents
(Simon, Czobor, Balint, Meszaros, & Bitter, 2009). Scholars debate whether ADHD can be
validly and reliably diagnosed, citing patterns of over-diagnosis and under-diagnosis in children
and adults (Bruchmuller et al., 2012; Cuffe, Moore, & McKeown, 2005; Ginsberg, Quintero,
Anand, Casillas, & Upadhyaya, 2014; Sibley et al., 2016; Young & Goodman, 2016). Wakefield
(2015) claimed that there is “overwhelming evidence” that ADHD is highly over-diagnosed
leading to a “massive false-positives problem” (p. 193). Such a trend risks pathologizing
normative behavior, which Frances and Widiger (2012) cautioned could result in largescale
consequences in medication side effects, stigma, and insurance problems. Elder (2010) estimated
that between $320 and $500 million is spent annually on pharmacological treatment for
individuals with invalid diagnoses of ADHD.
Other scholars have contended that ADHD is not itself a distinct entity, but rather a
constellation of symptoms from multiple disorders (Weinberg & Brumback, 1992). This position
is supported by research that suggests that each subtype originates in distinctive brain regions
(Stevens, Pearlson, Calhoun, & Bessette, 2018). fMRI scans revealed that children with
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impairment in executive functions and reward management demonstrated separate brain
abnormality through individual, functionally specialized neurobiological pathways. Mallett et al.
(2014) argued that recent changes to the diagnostic criteria for ADHD “are supported by limited
and, at times, contradictory validity evidence” (p. 46). These authors added that “there simply is
not sufficient empirical evidence to have confidence that the mental health field in the United
States has ADHD diagnosis correct” (p. 46). What these and other critics may point to is
ambiguity in our understanding of the etiology, pathophysiology, and epidemiology of ADHD.
Our ability to accurately assess and diagnose ADHD is limited by an incomplete, albeit evolving
explanatory model of the disorder.
Presently there is no single diagnostic tool that represents the “gold standard” for
identifying ADHD. Current assessment methods involve a combination of measures including a
structured diagnostic interview, current and retrospective self-report, collateral reports from
multiple sources intended to verify impairment history (e.g., parent and teacher rating forms), a
computer-based continuous performance test (CPT), and a symptom validity measure. Although
a plethora of diagnostic instruments are currently available, there remains no clear agreement on
the most appropriate composition of a test battery (Fuermaier, Fricke, de Vries, Tucha, & Tucha,
2018; Huang-Pollock, Karalunas, Tam, & Moore, 2012).
Self-Report. Self-report measures of current and past functioning are often a core feature
in ADHD evaluations (Taylor, Deb, & Unwin, 2011). Retrospective assessment is especially
critical with adult patients to establish or rule-out a childhood impairment history. This is
however a difficult task as patients often serve as the primary informants regarding their
childhood experiences. Inclusion of retrospective versus prospective data is important based on
evidence from Moffitt and colleagues (2009) that lifetime prevalence rates of mental disorders
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are doubled when prospective methods are used. Additionally, reliance on self-report in the form
of retrospective recall to establish childhood symptoms is known to be inaccurate and unreliable
(Miller, Newcorn, & Halperin, 2010; Sibley et al., 2012), and vulnerable to feigned
symptomatology (Bryant et al., 2018).
Accurate recall is crucial because childhood impairment is a prerequisite for an ADHD
diagnosis in adulthood based on the current criterion set (APA, 2013). Inaccurate recall can lead
to difficulties in determining the development and trajectory of the disorder. One longitudinal
study with young adults highlighted low to barely moderate correspondence (r = .16 – .32)
between retrospective and prospective self-reported measures of childhood hyperactivity (Henry,
Moffitt, Caspi, Langley, & Silva, 1994). Based on relatively low agreement on a variety of
psychosocial variables, the authors concluded that retrospective self-report measures in social
science research should be used with caution. Continuing this line of inquiry, an ADHD
diagnosis was shown to be at least 9-11 times more likely using parent-report than with selfreport at follow-up in young adulthood (Barkley, Fischer, Smallish, & Fletcher, 2002).
Participants tended to retrospectively underreport their childhood symptoms, rendering them
increasingly ineligible for a diagnosis.
In contrast, Murphy and Schachar (2000) found significant positive correlations between
adults’ self-reports of childhood symptoms and retrospective ratings of childhood symptoms
provided by parents. With a second sample, Murphy and Schachar (2000) reported significant
positive correlations between adult self-reports of current symptoms with ratings provided
simultaneously by partners. Favorably, the revised age-of-onset criterion (APA, 2013) may be
advantageous in that it minimizes error in retrospective report by reducing the necessary
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recollection period and emphasizes middle rather than early childhood. Both may enhance
predictive validity.
The use of self-report measures in social science research leads to internal validity
concerns based on potential confounding variables such as self-deceptive enhancement (Pauls &
Crost, 2004), positive impression management (Bolino, Kacmar, Turnley, & Gilstrap, 2008), and
social desirability (Crowne & Marlowe, 1960). Self-deceptive enhancement refers to an
unwitting response style characterized by inflated or overly favorable self-report (Pauls & Crost,
2004). Positive impression management refers to a method of self-presentation wherein a
response pattern reflects intentional effort to present oneself in a favorable manner (Weiss,
Weiss, Cain, & Manley, 2009). Social desirability refers to biased responding based on social
norms whereby responses represent social artifacts rather than raters’ pure relationships to or
perceptions of the variable(s) of interest (King & Bruner, 2000). Social desirability is considered
a robust threat to the validity of self-report measures, likely to result in underreporting of
negative experiences (Ben-Porath, 2013; Huang, Liao, & Chang, 1998). Meta-analytic data
showed that only 31 of over 14,000 health-related research studies (i.e., 0.22%) accounted for
social desirability response bias (van de Mortel, 2008). Under these circumstances, self-report is
likely to be inaccurate in that impairment is underreported and presentations are overly
favorable.
Recall bias represents a major threat to internal validity in retrospective research using
self-reported data (Hassan, 2006). Research has shown that self-evaluation among children and
adults with ADHD is prone to underreporting of symptoms and impairment on performance
related measures (Hoza, Vaughn, Waschbusch, Murray-Close, & McCabe, 2012; Knouse,
Bagwell, Barkley, & Murphy, 2005; Kooji et al., 2008; Owens, Goldfine, Evangelista, Hoza, &
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Kaiser, 2007; Owens & Hoza, 2003). Across these studies, self-ratings of performance were
consistently higher than those of collateral informants. Diener and Milich (1997) point to
positive illusory bias as an explanation for this pattern, which they described as a self-protective
mechanism whereby children with ADHD enhance their self-view in areas of deficit to mitigate
the impact of underperformance. Generally, a tendency to underreport symptom severity on selfreport measures may result in misdiagnosis or prohibition from appropriate services. Despite
threats to validity associated with self-report measures, clinicians have historically used them to
assess symptom presence, severity, and history (Harrison, Edwards, & Parker, 2007).
Feigning Symptoms for Secondary Gain. Another threat to the validity of self-report
measures is impression management in the opposite direction, or over-reporting symptoms. Selfreport ADHD measures have shown minimal test specificity to feigned impairment resulting in
false positives (Fisher & Watkins, 2008; Jachimowicz & Geiselman, 2004). Symptom
exaggeration may be especially likely in the presence of secondary gain (Bryant et al., 2018;
Leppma et al., 2017), and especially feasible as information about ADHD symptoms and
diagnostic procedures is readily accessible on the internet (Sollman, Ranseen, & Berry, 2010).
One incentive for feigning ADHD symptoms is potential access to medication (Leppma
et al., 2017), including those classified as psychostimulants (e.g., Adderall) and non-stimulants
(e.g., Straterra). Such medications are generally regarded as a first-line therapy for adults with
ADHD (Asherson, 2016; Cubillo & Rubia, 2010). Additionally, a diagnosed disability such as
ADHD renders one potentially eligible for tax benefits and government funded programs, or to
have student loan repayments waived (Harrison et al., 2007). For university students, a diagnosis
of ADHD may result in eligibility for accessibility services and academic accommodations
(Leppma et al., 2017).
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Recently, there has been an increase in stimulant medication prescriptions in the U.S.
(Sollman et al., 2010) and a 35% increase annually outside of the U.S. (Zetterqvist, Asherson,
Halldner, Langstrom, & Larsson, 2013). In a U.S. database for outpatient physician visits, 87%
of children and adolescents diagnosed with ADHD were treated with psychostimulants (Garfield
et al., 2012). With a nationwide increase in stimulant medication prescriptions comes greater
need for assessment methods that are sensitive to symptom over-reporting. Research has shown
that 25-48% of adults may perform sub-optimally and exaggerate their symptoms on ADHD
assessments when motivated by secondary gain (Constantinou, Bauer, Ashendorf, Fisher, &
McCaffrey, 2005; Sullivan, May, & Galbally, 2007).
One incentive to receive a diagnosis of ADHD is to gain access to stimulants to then
divert the medication for profit (Schultz, Silvestri, & Correia, 2017). Diversion of medication
was found to occur in 58.9% of university students with stimulant prescriptions (Galluci, Martin,
& Usdan, 2015). Non-medical use of prescription stimulants has increased from 5.3% in 2008
(DuPont, Coleman, Bucher, & Wilford, 2008) to 17% of students according to recent metaanalytic data (Benson, Flory, Humphreys, & Lee, 2015). Individual studies have found that as
many as 43% of undergraduates reported misusing their medication (Advokat, Guidry, &
Martino, 2008). Students may be willing to pay more than $10 per pill (Cruz, Sumstine, Mendez,
& Bavarian, 2017), which may explain why young adults are increasingly presenting at
university counseling centers with ADHD symptoms (Harrison et al., 2007; Benson et al., 2015).
As stimulant prescription misuse has been associated with a variety of poor medical and
academic outcomes (Benotsch, Koester, Luckman, Martin, & Cejka, 2011; Egan, Reboussin,
Blocker, Wolfson, & Sutfin, 2013; Reid et al., 2015; Westover & Halm, 2012), it is critical that
assessment tools are sensitive to feigned ADHD symptomatology.
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Leppma and colleagues (2017) recommended including a performance validity measure
in ADHD assessments to detect deliberate underperformance or effort to feign or exaggerate
symptoms. One such measure is the Non-Verbal Medical Symptom Validity Test (NVMSVT;
Green, 2008). The NVMST was found to discriminate between test-takers with suboptimal effort
and control groups comprised of adults with dementia and youth with fetal alcohol syndrome.
Examinees’ performances are compared to these control groups to determine the likelihood of
suboptimal performance. Green (2008) noted that patients with dementia almost never fail all
four validity criteria and seldom fail even two, whereas malingerers often fail all four criteria.
Such a measure can aid diagnosticians in detecting deliberate underperformance.
Continuous Performance Tests. Continuous Performance Tests (CPT) are currently
among the most frequently employed instruments in ADHD evaluations (Munkvold, Manger, &
Lundervold, 2014; Sollman et al., 2010). CPT methodology was introduced in a study of the
effects of brain damage on sustained attention and impulsivity (Rosvold, Mirsky, Sarason,
Bransome, & Beck, 1956). Inferior performance by patients with brain damage was attributed to
deficits in neuropsychological functioning, including diminished capacity for sustained attention.
CPT was later used to assess signal detection, vigilance, and arousal among radar operators
(Mackworth & Taylor, 1963). Results from these early studies prompted subsequent clinical
research using CPT with psychiatric populations to measure neuropsychological impairment in
individuals with attention deficits (Epstein et al., 2003).
CPT is a neuropsychological instrument intended to objectively and quantitatively
measure sustained attention and response control, also known as inhibitory motor control and
motor response inhibition (Alderson et al., 2007). Sustained attention refers to the ability to
maintain a state of alertness over an extended period (Huang-Pollock et al., 2012), which is a

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

30

capacity thought to be compromised in individuals with ADHD (Adler et al., 2017). Motor
response inhibition is defined as the “ability to withhold a speeded motor response prior to its
initiation or the ability to cancel a response after it has been initiated” (Wright, Lipszyc, Dupuis,
Thayapararajah, & Schachar, 2014, p. 429). Deficits in these two processes, action restraint and
action cancellation, respectively, were evidenced by poorer performance among ADHD children
on such measures compared to healthy controls (Schachar et al., 2007). Response inhibition is
also considered a reflection of aspects of impulsivity (Bari & Robbins, 2013), playing a critical
role in supporting flexible, goal-directed behavior amid environmental changes (Verbruggen &
Logan, 2008).
CPT quantifies performance on measures of attention and response control based on
patterns of omission and commission errors, respectively (Uno et al., 2006). Omission errors
refer to missed responses, or failure to respond to target stimuli, which is traditionally considered
to reflect inattention (Berger & Cassuto, 2014). Commission errors refer to incorrect responses to
non-target stimuli, or failure to inhibit a response, which is believed to reflect impulsivity. CPT
provides a more objective alternative to reliance on subjective and retrospective recall, thereby
countering the validity concerns that are traditionally associated with self-report measures.
Today, some of the most widely used CPTs include the Conners’ CPT – 2nd Edition (CCPT-II; Conners, 2000), the Tests of Variables of Attention (TOVA; Greenberg & Waldman,
1993), and the Integrated Visual and Auditory Continuous Performance Test (IVA; Sandford &
Turner, 1995). The C-CPT-II and the TOVA measure sustained attention and response inhibition
in the visual domain. The C-CPT-II presents a predetermined series of stimuli, 90% of which are
targets and 10% are non-targets. Conversely, the TOVA presents a different ratio of targets to
non-targets between the two halves of the test (Greenberg & Waldman, 1993). The IVA
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combines aspects of both tests into a dual stimulus model in which stimuli are presented in the
visual and auditory domains. Examinees are presented with a pseudorandom series of auditory
and visual targets (“1”) and non-targets (“2”). Performance is assessed based on omission and
commission errors, response times to targets, and response accuracy. Research has shown
adequate convergence across commonly used CPTs (r = .42; Borgaro et al., 2003) based on the
multitrait-multimethod matrix for convergent and discriminant validation (Campbell & Fiske,
1959).
Clinical Utility. The use of continuous performance tests in clinical assessment of ADHD
is well-supported in the literature. Numerous studies have shown that CPT can be useful in
differentiating between ADHD and non-ADHD groups (Losier, McGrath, & Klein, 1996;
Epstein et al., 2003; O’Dougherty, Neuchterlein, & Drew, 1984; Sonuga-Barke, Sergeant, Nigg,
& Willcutt, 2008; Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). In a meta-analytic
review of 26 studies of CPT performance, children with ADHD were found to make significantly
more errors of omission and commission compared to controls (Losier et al., 1996). Results
indicated that children with ADHD, on average, make about twice as many errors of omission
and commission compared to non-ADHD children. CPT performance has also been used to
differentiate ADHD subtypes (Marks, Himelstein, Newcorn, & Halperin, 1999).
A study by Quinn (2003) provided support for the inclusion of the IVA in ADHD
evaluations. The study examined three randomly assigned groups of undergraduate students: (1)
students with valid ADHD diagnoses, (2) simulated malingerers, and (3) healthy controls. Data
was collected using a self-report ADHD checklist and the IVA CPT. Quinn (2003) hypothesized
that simulated malingerers could successfully feign ADHD on the self-report checklist, but that
they would be unsuccessful on the IVA due to overcompensation and lower scores than the
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clinical group. As hypothesized, results showed that the self-report checklist lacked specificity
and could be successfully feigned, whereas malingerers scored significantly below students with
ADHD on 81% of subscales. The findings supported a tendency to overcompensate among
malingerers in attempting to feign ADHD. Quinn (2003) concluded that a self-report measure by
itself is neither sensitive nor specific enough for clinical use. ADHD evaluations may also
include a CPT as a supplemental diagnostic tool to improve test sensitivity and specificity.
Not all studies report favorable results, however. In one study of 201 adults diagnosed
with and treated for ADHD, only 51.7% of the participants were classified as having the disorder
based on their CPT performance (Baggio et al., 2019). In a study of the original Conners’ CPT
(Conners, 1995), researchers found no significant differences in performance between children
referred for learning disorder and/or ADHD assessment and controls (McGee, Clark, & Symons,
2000). The instrument was deemed to be of minimal clinical utility for differential diagnosis
based on this sample. A subsequent study corroborated the finding that differential diagnoses
between ADHD and learning/cognitive disorders in adults could not be determined based on
CPT performance (Advokat, Martino, Hill, & Gouvier, 2007).
Likewise, Tollander (2011) called into question the ability of the IVA to differentiate
between ADHD and non-ADHD groups. The study focused specifically on the Comprehension
subscale, which measures atypical error patterns thought to reflect random or impulsive
responding, carelessness, and inattention. Developers of the IVA claimed that Comprehension is
the “single most sensitive subscale in discriminating ADHD” (Sandford & Turner, 2004, p. 10).
Based on this assertion, Tollander (2011) expected Comprehension scores to differ significantly
between ADHD participants and controls. Instead, the subscale correctly identified participants
in each group only at chance levels. Additionally, CPT scores have been shown to be unrelated
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to parent and teacher ratings of ADHD symptoms among clinically referred children (Edwards et
al., 2007).
Another concern is the ability of CPT to reliably differentiate between ADHD and other
disorders. Mood and anxiety disorders often result in false positives on CPT (APA, 2013),
perhaps due to known associations between anxiety disorders and response inhibition (Quay,
1988). Low specificity for individuals with other psychiatric conditions means that low CPT
performance may not be specific to ADHD (Fuermaier et al., 2018), but may represent
neuropsychological deficits associated with other psychiatric disorders.
Epstein et al. (2003) added that relationships between CPT variables and ADHD
symptoms have not been equivocally and consistently demonstrated. Researchers pointed to
commission errors as an example, citing an assumed connection between commission errors and
impulsivity based on incorrect or inappropriate responding. However, in their study, four of five
CPT parameters were related to all three ADHD symptom domains, making it difficult to
determine which variables map onto which symptoms. Mean reaction time was the only variable
to be significantly related with one symptom domain (i.e., hyperactivity); however, it was
correlated with only one of the 18 ADHD symptoms. Generally, research has not yet definitively
demonstrated which CPT parameters measure which ADHD symptoms. More research is needed
to advance our understanding of the ADHD endophenotype to develop instruments that address
the limitations of existing CPT.
Go/No-Go Methodology. CPT involves detecting and responding to visual or auditory
target stimuli amid a continuous and rapid stream of distractors for a period of 10-30 minutes.
Examinees are instructed to respond when presented with target stimuli and to inhibit a response
to non-targets. Different versions of CPT have been developed. For example, in the “X version”
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(Ogundele, Ayyash, & Banerjee, 2011), a common CPT format, examinees are presented with a
series of stimuli and are instructed to respond only to the single target stimulus, the letter “X.”
All other stimuli are non-targets to be resisted. Variations of this format exist in which the
examinee is instructed to respond to all stimuli except the letter “X.” The frequency of targets
may vary across CPTs and/or conditions from about 90% to 10%; the former measures response
inhibition to seldom presented non-targets and the latter measures sustained attention for
infrequent targets.
Generally, these CPTs are referred to as “Go/No-Go” tasks (G/NG; Donders, 1969) due
to the need to initiate a response (Go) or inhibit a response (No-Go) depending on stimulus
presentation. The “go” response is proposed to be initiated within the brain’s Behavioral
Activation System, whereas the “no-go” response originates in the Behavioral Inhibition System
(Gray, 1987). G/NG tasks are designed to measure the action restraint component of response
control in the “no-go” condition (van Velzen et al., 2014).
Interference Control. G/NG tasks are made more difficult by including visual or auditory
distractors within test stimuli, thereby invoking interference control (Uno et al., 2006; van
Velzen et al., 2014). Recall that Schachar et al. (2007) assessed performance on two primary
components of response control: action restraint and action cancellation. A third process,
interference control, is required when stimuli are presented alongside environmental distractors.
Examinees must resist attending to the distractors and attend only to task-relevant stimuli,
thereby increasing the demand for sustained attention (Shalev, Ben-Simon, Mevorach, Cohen, &
Tsal, 2011). Research suggests that CPT with environmental distractors is useful in identifying
ADHD among adolescents (Berger & Cassuto, 2014). The ADHD group was identified based on
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a significantly greater number of omission errors compared to the non-ADHD group, which
provides evidence for deficient sustained attention among members of the clinical sample.
Interference control can be measured by a variety of tasks including the Flanker task
(Eriksen & Eriksen, 1974), the Simon task (Rubia, Cubillo, Woolley, Brammer, & Smith, 2011)
and the Stroop task (Stroop, 1935; MacLeod, 1992). The Flanker task presents a target stimulus,
typically an arrow pointing in one direction or another. Subjects are to push a button
corresponding to the direction of the target arrow; however, the target arrow is flanked by nontarget distractors that point either in the same direction (in congruent trials) or the opposite
direction (in incongruent trials) as the target. Subjects therefore must ignore the flankers, or
control the interference they present, and maintain their attention on target stimuli.
The Simon task presents an arrow pointing left or right on either the left or right side of
the screen. In congruent trials, the left and right pointing arrows appear on the left and right side
of the screen, respectively. In incongruent trials, the target arrow is pointing in the opposition
direction of its location on the screen. Subjects push a left/right button depending on whether the
arrow points left or right while ignoring the position of the target arrow on the screen.
The Stroop task involves naming colors that appear as written words either in the same
color ink (in congruent trials) or different color ink (in incongruent trials). A congruent trial
would present the word red written in red ink, whereas an incongruent trial would present the
word blue written in red ink. Responders are asked to read aloud a set of written words that are
either congruent or incongruent with respect to ink color. Each of these three tasks involve
interference control in the presence of non-target distractor stimuli (van Velzen et al., 2014).
Stop Signal Paradigm. At a higher level of inhibitory demand is a G/NG task that
includes the stop-signal task (SST; Logan, 1981; Logan & Cowan, 1984). SST adds a layer of
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cognitive complexity by presenting a stop-signal immediately following a target stimulus,
typically within 50-500 milliseconds. The stop-signal is commonly presented as an auditory tone
that indicates to subjects to withhold a pre-trained target response. Pairing a target stimulus with
a stop-signal forces subjects to cancel an already initiated response, or to apply the “mental
breaks,” which increases the demand for inhibitory control (Schachar et al., 2007). Whereas
basic G/NG tasks are intended to measure action initiation in “go” conditions and action restraint
in “no-go” conditions, SST measures an additional and more complex process in action
cancellation. It is the task with the greatest inhibitory load because the “go” process must be
quickly overridden by the “stop” process in response to stop-signals (Schachar et al., 2007; van
Velzen et al., 2014).
The G/NG task is based on a theoretical model wherein the “go” and “no-go” processes
function independently (Logan & Cowan, 1984). Known as the race model (Logan, 1994), it
refers to the competition between two opposing processes, the response initiation and response
inhibition processes. Whichever process wins the “race” determines the behavioral outcome. In
support of Logan’s (1994) model, Dambacher et al. (2013) used fMRI to show that action
restraint and action cancellation occupy distinct neural networks. Motor response inhibition is
therefore not a unitary construct and is instead multifaceted consisting of action restraint, action
cancellation, and interference control (van Velzen et al., 2014). Sebastian et al. (2013) proposed
that interference control, action restraint, and action cancellation involve early, intermediate, and
late response inhibitory processes, respectively. Barkley (1997) had previously used alternative
labels to describe the same three processes: (1) inhibiting interference, (2) inhibiting prepotent
responses, and (3) stopping an ongoing response.
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The SST paradigm quantifies inhibitory control processes using the following metrics:
mean reaction time to targets (MRT), stop-signal delay (SSD), reaction time variability (SDRT),
and stop-signal reaction time (SSRT) (Alderson et al., 2007). MRT measures latency of the
response execution process. It represents the average time required to perceive target stimuli and
execute responses across a designated number of trials. SDRT supplements MRT by providing
the standard deviation of reaction times to targets across trials. SSD is the average time between
presentations of the target and stop-signals (i.e., SSD = MRT – SSRT). SSRT measures latency
of the response inhibitory process and is normally distributed (Teichert & Ferrera, 2015;
Verbruggen & Logan, 2008). SSRT is a function of the relationship between MRT and SSD (i.e.,
SSRT = MRT – SSD) and reflects the speed of the action cancellation process.
The SSD may use a fixed, variable, or tracking go-stop method for determining the
frequency and timing of stop-signals (Lijffijt et al., 2005). A fixed method uses a predetermined
interval to establish the ratio of go stimuli to stop-signals. A variable method uses an interval that
varies as a function of MRT. The tracking method was developed to counter subjects who may
compromise speed to enhance accuracy, or engage in a speed-accuracy trade-off, whereby MRT
increases as subjects delay responses to targets in anticipation of a stop-signal (Logan, Schachar,
& Tannock, 1997). Schachar et al. (2004) provided evidence for error monitoring or “detection
of errors and subsequent adjustment of performance” (p. 285). The results demonstrated that
children with ADHD artificially and differentially slowed their reaction time to targets following
unsuccessful performance compared to controls. To address this effect, some measures now
employ a tracking algorithm for SSD in which the stop-signal delay is increased by 50ms
following successful response inhibition and decreased by 50ms following unsuccessful response
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inhibition. This algorithm produces a desired success rate of about 50% across all trials
(Alderson et al., 2007).
A meta-analysis of eight studies (n = 456) of SST provided support for MRT and SSRT
in differentiating children with ADHD from controls (Oosterlaan et al., 1998). Regarding MRT,
latency for responding was significantly slower for ADHD children compared to controls,
suggesting deficits in action initiation associated with inattention. Regarding SSRT, children
with ADHD exhibited deficits in action cancellation by taking significantly longer (i.e., 103ms,
on average) to respond to stop signals compared to controls, indicating relatively poor response
control. These results support the use of MRT and SSRT in differentiating children with ADHD
from non-ADHD controls.
A subsequent meta-analysis by Lijffijt and colleagues (2005) replicated and extended the
work of Oosterlaan et al. (1998) by including 29 articles published in the seven years between
studies. The review also included studies of adults with ADHD, whereas the original analysis
examined only children. The purpose was to investigate whether ADHD is primarily
characterized by response control deficits or impaired attention. The results corroborated
previous findings of a significant difference in SSRT between ADHD children and adults
compared to matched controls, suggesting deficient response control in this clinical population.
Additionally, MRT differentiated ADHD from control groups in children, but not in adults,
providing partial support for the use of this metric to identify young patients with ADHD. Taking
both reviews together, MRT and SSRT were successfully used to differentiate between clinical
and non-clinical groups among children, while SSRT was the metric that differentiated groups in
the adult sample.
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Among children with ADHD, Lijffijt et al. (2005) found no significant differences
between MRT and SSRT, which the authors concluded was possibly indicative of underlying
cognitive impairment (e.g., inattention) rather than deficits in response control. For SSRT to
reflect deficient response control, SSRT values must be disproportionately larger compared to
MRT or there is no way to rule-out confounding variables such as impaired attention. An
insignificant difference between MRT and SSRT suggests possible deficits in attention based on
MRT as well as in response control based on SSRT. However, significant variability in SDRT (a
function of MRT) was found among children with ADHD, which provides additional evidence
for lapses of attention based on high variability in response latency to targets. This conclusion
was supported by Epstein et al. (2010) who demonstrated that reaction time was slower for trials
before and after errors of omission. Insignificant differences between MRT and SSRT, and
significant variability in SDRT both point to impaired attention as a primary characteristic of
ADHD over and above response control deficits.
Although no differences in MRT were observed between the adult clinical and control
groups, SSRT was significantly different between groups. Additionally, unlike in children,
significant differences between MRT and SSRT in adults suggested deficient response control
independent of other potential cognitive impairment, such as inattention.
Results from these two meta-analyses are mixed regarding the utility of each metric to
differentiate between ADHD and control groups. It appears that the composition of the sample
may be an important factor, as different results are reported for child and adult samples.
Oosterlaan et al. (1998) showed that both MRT and SSRT are clinically useful with children.
Lijffijt et al. (2005) pointed specifically to MRT as the key metric among children. Their
analysis also provided initial support for the use of SSRT with adults to differentiate between
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groups based on impaired response control. Considering these initial findings, it remains to be
investigated whether ADHD is characterized primarily by deficient response control or by
inattention, and whether this primary deficit may differ across age groups. It is also important to
consider the extent to which impairment is attributable to cross-circuit interactions.
A subsequent meta-analytic review replicated the Oosterlaan et al. (1998) and Lijffijt et
al. (2005) findings of significantly slower MRT among ADHD children relative to controls
(Alderson et al., 2007), indicating impairment in action initiation. Moreover, significant
differences in SDRT and insignificant differences in between-group SSD (i.e., MRT – SSRT)
both replicated the Lijffijt et al. (2005) results and further supported a potential generalized
attention deficit based on differences in MRT rather than impairment in response control based
on SSRT.
Overall, these meta-analyses provide a valuable, yet preliminary contribution to our
understanding of ADHD by highlighting deficient response control and inattention as core
features of the disorder. The results support the use of MRT and SSRT in differentiating between
ADHD and non-ADHD groups, especially among children. Oosterlaan et al. (1998) found
medium combined estimated effect sizes for MRT (d=0.40) and SSRT (d=0.64) using Cohen’s
standards (Cohen, 1988). Using Lipsey and Wilson’s (2000) procedures, Lijffijt et al. (2005)
found a significant medium effect size using MRT (0.52) and SSRT (0.58) among children. A
medium, almost large, effect size (0.79) was also significant for SSRT among adults. Alderson et
al. (2007) found significant medium mean effect sizes for MRT (0.45) and SSRT (0.63) among
children using Hedges’ standards (Hedges, 1982). The analysis of adult patients (Lijffijt et al.,
2005) found a significant effect size for SSRT, which is medium (0.79) but close to the threshold
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for a large effect (Lipsey & Wilson, 2000). At least two additional studies have found significant
large effect sizes for SSRT in adult samples (Aron et al., 2003; Wodushek & Neumann, 2003).
More research is needed to corroborate and clarify whether metrics associated with
inattention (i.e., MRT) and/or response control (i.e., SSRT) are clinically useful in evaluating
ADHD in child and adult patients. Inattention is highlighted as a predominate deficit in studies
involving children (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan et al., 1998), whereas
deficient inhibitory control has been proposed as the major feature of adult ADHD (Bekker et al.,
2005; Lijffijt et al., 2005). SSRT was significantly more prolonged than MRT among adults,
which supports Barkley’s (1997) theoretical model in which response inhibitory deficits are
primary in ADHD. All other impairments are proposedly secondary as their function is
contingent on effective and efficient response inhibition. Evidence of deficient inhibitory control
may also illuminate key neuroanatomical structures involved in ADHD based on their
association with motor response inhibition including the basal ganglia (Guo et al., 2018; Shaw et
al., 2014), frontal gyrus, posterior cingulate cortex, and parietal regions (Dambacher et al.,
2013).
Support for Barkley’s (1997) model is limited based on results from these meta-analyses
for the following reasons. First, due to significant differences in SDRT and insignificant
differences in SSD among children, both Lijffijt et al. (2005) and Alderson et al. (2007)
concluded that clinical and non-clinical groups may differ based on action initiation (i.e.,
inattention) rather than on action cancellation (i.e., response control). When no difference exists
between MRT and SSRT, the between-group variability may be attributable to a general deficit
in cognitive control rather than a selective deficit in inhibition (Verbruggen & Logan, 2008).
Second, the meta-analyses included only studies of CPT performance in the basic G-NG format
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without non-target distractor stimuli. There was therefore no analysis of CPT performance with
greater cognitive processing demands. The studies merely addressed response inhibition on a
task of lower cognitive complexity without the additional inhibitory load introduced by
interference control (Uno et al., 2006; van Velzen et al., 2014). Third, only one of the reviews
included an adult sample, thus the conclusions made about SSRT among adult ADHD patients
remain limited and warrant further exploration.
Based on these limitations and mixed results, further investigation is needed to determine
the clinical utility of SSRT relative to MRT in differentiating between groups amid higher
cognitive processing demands. Significant differences between SSRT and MRT under these
conditions may provide evidence for a selective deficit in response control among individuals
with ADHD (Verbruggen & Logan, 2008). Moreover, this finding would provide contrary
evidence for the conclusions of Lijffijt et al. (2005) and Alderson et al. (2007) that periodic
lapses in attention are primarily responsible for between-group variation. Indeed, in a more
recent meta-analysis of reaction time variability among children, adolescents, and adults with
ADHD, Kofler et al. (2013) found that what accounted for group variation was SDRT, not MRT.
Participants demonstrated significantly greater reaction time variability relative to controls, even
after controlling for MRT.
In sum, ADHD is a complex neurodevelopmental disorder. Accurate assessment is
complicated by a variety of factors including symptom heterogeneity (Uno et al., 2006),
variability in functional impairment (Spencer et al., 2007), comorbid disorders (Faraone et al.,
2000), and potentially insufficient or inadequate measures. While CPT is prevalent in ADHD
evaluations (Munkvold, Manger, & Lundervold, 2014; Sollman et al., 2010), different versions
have shown mixed utility in identifying ADHD and non-clinical groups, as well as differentiating
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ADHD from other psychiatric disorders (Advokat et al., 2007; Fuermaier et al., 2018; McGee,
Clark, & Symons, 2000; Tollander, 2011). As our understanding of ADHD genotypes,
phenotypes, and endophenotypes evolves, we must advance our assessment tools to increase
instrument specificity and sensitivity.
Cognitive control deficits associated with motor response inhibition have been identified
as a core feature of ADHD (Hart et al., 2014; McAuley et al., 2013). Specifically, stop-signal
inhibition has been proposed as a key endophenotype (Aron & Poldrack, 2005; Schachar et al.,
2005) and research has demonstrated the clinical utility of SST in identifying ADHD and control
groups on G/NG tasks (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan et al., 1998). Absent
from this literature is assessment of the diagnostic utility of stop-signal tasks in the adult
population on tasks with greater central processing demands produced by interference control.
The Present Study
Research Questions
CPT has evolved from G/NG tasks intended to measure action initiation and action
restraint to central processing tasks involving higher cognitive demands associated with action
cancellation and interference control. Previous research has identified MRT (i.e., inattention) as
the primary metric that differentiates ADHD patients from non-clinical controls (Alderson et al.,
2007; Lijffijt et al., 2005). Between-group variability was attributed to inattention based on
insignificant differences between MRT and SSRT, as well as significant differences between
groups on SDRT. Both results suggest that an underlying factor other than inhibitory control,
such as inattention, may account for the variability. These findings are consistent with the
position of Castellanos and Tannock (2002) that “perhaps that most striking clinical
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characteristics of ADHD include the transient but frequent lapses of attention, and the momentto-moment variability and inconsistency in performance” (p. 624).
In contrast, when SSRT is impaired but MRT is not, the results may suggest a selective
deficit in the action cancellation facet of motor response inhibition (Verbruggen & Logan, 2008).
The purpose of the present study was to examine the relationships between scores on a selfreport measure of adult ADHD symptoms and CPT performance. The primary aim was to
determine whether SSRT may predict levels of self-reported impairment from ADHD symptoms
among adults on a CPT with greater central processing demands. This study addressed the
following three research questions:
1. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict selfreported symptoms of inattention, as measured by the Inattention subscale of the
ASRS-V1.1 (Kessler et al., 2005), over and above MRT alone, as measured by the
TDIA (Long, 2018)?
2. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict selfreported symptoms of hyperactivity/impulsivity, as measured by the HyperactivityImpulsivity subscale of the ASRS-V1.1 (Kessler et al., 2005), over and above MRT
alone, as measured by the TDIA (Long, 2018)?
3. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict selfreported symptoms of combined inattention and hyperactivity/impulsivity, as
measured by the ASRS-V1.1 total score (Kessler et al., 2005), over and above MRT
alone, as measured by the TDIA (Long, 2018)?
Hypotheses
In light of previous literature and based on the aforementioned research questions, the
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following three hypotheses were established for the current study:
H1. SSRT will significantly predict self-reported symptoms of inattention, over and
above MRT alone.
H2. SSRT will significantly predict self-reported symptoms of hyperactivity/impulsivity,
over and above MRT alone.
H3. SSRT will significantly predict self-reported symptoms of combined inattention and
hyperactivity/impulsivity, over and above MRT alone.
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CHAPTER 2: METHODS
I designed this study to replicate and extend previous research on stop-signal tasks (SST)
that identified stop-signal reaction time (SSRT) as the primary parameter that differentiates
adults with ADHD from non-clinical controls (Lijffijt et al., 2005). Whereas the analysis by
Lijffift and colleagues (2005) included only basic “Go / No-Go” tasks (G/NG), I examined the
performances of adults on a continuous performance test (CPT) with interference control
conditions. I also extended previous research showing that a CPT with distractor stimuli aided in
identifying ADHD among adolescents (Berger & Cassuto, 2014), by replicating this result in an
adult sample. While the CPT with distractors differentiated between clinical and non-clinical
groups, the sample did not include adults and SST was not involved. Scholars have not yet
examined the performances of adults on a CPT that includes both SST and distractor stimuli.
In this study I examined the relationships between scores on a self-report measure of
adult ADHD symptoms and performances on a CPT with SST and interference conditions. My
primary aim was to preliminarily assess the clinical utility of SSRT in distinguishing between
adults with greater self-reported ADHD symptoms and those with lesser impairment based on
CPT performance with central processing demands. Research has shown that SSRT is useful in
identifying individuals with self-reported, clinically significant ADHD symptoms and
individuals with self-reported subthreshold impairment (Aron et al., 2003; Berger & Cassuto,
2014; Kofler et al., 2013; Wodushek & Neumann, 2003).
Research Design
In this study I employed a between-subjects, quantitative-descriptive, cross-sectional,
correlational design to define and describe the nature of the relationships between two
continuous predictor variables (i.e., MRT and SSRT) and the single continuous criterion variable
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(i.e., self-report ratings of adult ADHD symptoms). Two measures plus a demographic
questionnaire were administered to all participants. All participants received identical material,
and measures were counterbalanced to account for order effects.
Participants
All participants were required to be, and reported being, at least 18 years of age. An a
priori power analysis was calculated using G*Power software (Faul, Erdfelder, Buchner, &
Lang, 2009) to estimate the necessary sample size. A hierarchical multiple linear regression was
the primary statistical analysis selected, which included two continuous predictor variables (i.e.,
MRT and SSRT) and one continuous criterion variable (i.e., ASRS-V1.1 score). Based on an
alpha (α) level of .05, the power analysis estimated that a minimum of 31 participants was
necessary to obtain adequate statistical power (.80) to determine a large effect size using Cohen’s
f2 = 0.35 standards (Cohen, 1988). At least two studies have found significant large effect sizes
for SSRT in adult samples (Aron et al., 2003; Wodushek & Neumann, 2003).
Sampling Procedures
The study protocol was acknowledged by the WVU Office of Research Integrity and
Compliance’s Institutional Review Board (IRB). Initial recruitment of undergraduate and
graduate students at WVU was attempted using the online University Research Participation
System, SONA, managed by the WVU Department of Psychology. SONA provides WVU
psychology students with opportunity to participate in research to earn course credit. Alternative
assignments are typically available for students who choose not to participate in SONA research.
Students who register with SONA are provided a SONA ID number, which is used by SONA
administrators to track participation. Representatives of SONA distributed information about this
study to potentially eligible individuals within the SONA system via their webpage (see
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Appendix A). The study’s purpose and rationale were available to potential participants
including a detailed description of the eligibility requirements, anticipated completion time,
participation incentive, and the researcher’s contact information. Interested and eligible
individuals were invited to contact the researcher to obtain additional information about the
study or to express their desire to participate. However, this recruitment strategy was
unsuccessful in obtaining any participants.
The recruitment letter in Appendix A was also distributed via email to graduate students
and faculty in the Department of Counseling, Rehabilitation Counseling, and Counseling
Psychology at WVU, as well as alumni and associates of Kalamazoo College’s and Western
Michigan University’s Departments of Intercollegiate Athletics. The lead researcher also
personally recruited students from the Master of Arts in Counseling program at WVU during a
seminar on psychological assessment.
Participants were also recruited in the MindFit Clinic (MindFit) at the WVU Carruth
Center for Psychological and Psychiatric Services (Carruth). MindFit provides comprehensive
psychoeducational assessment, as well as cognitive and academic enhancement services in a
multidisciplinary program intended to improve students’ success in college. The staff is
comprised of approximately two doctoral practicum trainees in psychology, three pre-doctoral
psychology interns, and two licensed psychologists. All staff were trained on administration and
data collection procedures for all measures involved in this study. Specifically, staff received
training on procedures for recruiting participants, obtaining informed consent, maintaining
privacy and confidentiality, securely storing participants’ data, and referring students to
resources should they experience distress associated with participation in this study. All
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individuals who presented for testing at MindFit and met the inclusion criterion were invited to
participate in this study. Individuals were provided with a recruitment letter (see Appendix B).
MindFit provides approximately 50 comprehensive Learning Disorder and ADHD
evaluations annually. The standard battery includes a semi-structured diagnostic interview and
measures of intellectual functioning, academic functioning, executive functioning, attentional
processing and response control, sleep hygiene, and performance validity. Testing typically
occurs across two, three-hour appointments on separate days. Results are integrated in a written
report containing diagnostic impressions and treatment recommendations. Pending a request for
further action, evaluations conclude with a review of assessment findings and the provision of a
report to each client. Participants were informed that the measures involved in this study are not
used in any manner nor at any time during the assessment process. Information obtained for the
purposes of this study was not used in any manner for clinical or diagnostic purposes.
All interested and eligible individuals were directed to a paper-form, informed consent
document (see Appendix C) where they provided informed consent to participate. Survey
material was identical in form across all sampling procedures. For participants associated with
MindFit, administration of survey material occurred during either the first or second testing
appointment at the discretion of MindFit staff; however, participants were administered only one
CPT per appointment.
The sampling method used in this study is called convenience sampling (Heppner,
Wampold, & Kivlighan, 2008). Convenience sampling is a commonly used nonrandom sampling
method wherein participants are recruited for practical reasons such as proximity, accessibility,
and availability to the researcher (Bornstein, Jager, & Putnick, 2013; Etikan, Musa, & Alkassim,
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2016). The use of student volunteers as research participants is a common example of
convenience sampling (Bornstein et al., 2013).
Measures
World Health Organization Adult ADHD Self-Report Scale – V1.1 Symptoms Checklist
(ASRS-V1.1)
The World Health Organization Adult ADHD Self-Report Scale – V1.1 Symptoms
Checklist (ASRS-V1.1; Kessler et al., 2005) is a measure of self-reported symptoms of ADHD in
adulthood. The ASRS-V1.1 consists of 18 items that correspond to diagnostic criteria for ADHD.
The response format involves five frequency ratings on a five-point Likert-type scale: 0 (never),
1 (rarely), 2 (sometimes), 3 (often) and 4 (very often). None of the items are reverse scored,
meaning that higher ratings indicate greater frequency of impairment from ADHD symptoms for
all items. The ASRS-V1.1 total score is derived by summing points across all 18 items, with
possible scores ranging from 0 to 72. Higher total scores indicate greater frequency of symptom
impairment. Clinically significant symptom levels are defined as ASRS-V1.1 total score of 47 or
greater. ASRS-V1.1 total score of 46 or less indicate subthreshold impairment. This measure
takes approximately 5-10 minutes to complete (Gray, Woltering, Mawjee, & Tannock, 2014).
The ASRS-V1.1 consists of two subscales, Inattention and Hyperactivity-Impulsivity,
with nine items that correspond to each subscale and a range of possible scores from 0 to 36.
Higher total subscale scores indicate greater frequency of impairment for each symptom type.
Example items that load on the Inattention subscale include, “How often are you distracted by
activity or noise around you?” and “How often do you make careless mistakes when you have to
work on a boring or difficult project?” Example items from the Hyperactivity-Impulsivity
subscale include, “How often do you leave your seat in meetings or other situations in which you

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

51

are expected to remain seated?” and “How often do you have difficulty waiting your turn in
situations when turn-taking is required?” Items 1, 2, 3, 4, 7, 8, 9, 10, and 11 correspond to the
Inattention subscale. Inattention subscale total scores of 23 or greater indicate clinically
significant impairment. Items 5, 6, 12, 13, 14, 15, 16, 17, and 18 correspond to the
Hyperactivity/Impulsivity subscale. Hyperactivity/Impulsivity subscale total scores of 24 or
greater indicate clinically significant impairment.
The ASRS-V1.1 demonstrated adequate psychometric quality in comparison to blind
clinical assessment of adult ADHD in a community sample of 154 individuals (Kessler et al.,
2005). Participants completed a semi-structured clinical ADHD Rating Scale (ADHD-RS;
DuPaul, Power, Anastopoulos, & Reid, 1998), a semi-structured diagnostic interview for
symptoms of adult ADHD, and the ASRS-V1.1. Interviews were conducted by doctoral-level
clinical psychologists with a minimum five years of clinical experience. All 18 ASRS-V1.1
symptom measures were significantly related to their corresponding symptom rating during
clinical assessment. Cohen’s kappa values ranged from .16 to .81, indicating slight to substantial
concordance across all items using standards for assessing the strength of kappa coefficients
(Landis & Koch, 1977).
A second study of the ASRS-V1.1 yielded satisfactory ratings of internal consistency
reliability (Adler et al., 2006). Responses on the self-report ASRS-V1.1 were compared to
clinicians’ ratings on the ADHD-RS (DuPaul et al., 1998) for 60 adult patients diagnosed with
childhood onset adult ADHD. Internal consistency was assessed using Cronbach’s alpha. The
patient and clinician versions yielded Cronbach’s alpha coefficients of .88 and .89, respectively.
The ASRS-V1.1 also demonstrated sound psychometric properties in a sample of 135
English-speaking university students with a previous ADHD diagnosis (Gray et al., 2014).
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Responses on the self-report ASRS-V1.1 were compared to collateral reports of ADHD
symptoms using a modified version of the ASRS-V1.1, the ASRS-V1.1 for Other developed for
use in this study. Results indicated moderate congruence between self- and collateral-report
versions (r = 0.46, p < 0.001).
As discussed above, although self-report measures can be unreliable and of questionable
validity (Miller, Newcorn, & Halperin, 2010; Sibley et al., 2012), and vulnerable to feigned
symptomatology (Bryant et al., 2018), self-report measures are often a core feature of adult
ADHD evaluations (Taylor, Deb, & Unwin, 2011). Clinicians have historically used these
measures to assess symptom presence, severity, and history (Harrison, Edwards, & Parker,
2007).
Test of Differential Inhibition and Attention (TDIA)
The Test of Differential Inhibition and Attention (TDIA; Long, 2018) is a computerized,
20-minute CPT designed to assess differential contributions of various attention networks and
response inhibitory processes that may account for the variance in ADHD endophenotypes. CPT
is among the most frequently employed instruments in ADHD evaluations (Munkvold et al.,
2014; Sollman et al., 2010). The TDIA combines three different cognitive tasks: a modified
Posner cuing task (Posner, 1980) that incorporates an Eriksen Flanker design (Eriksen &
Eriksen, 1974) and the classic stop signal paradigm (Logan, 1981; Logan & Cowan, 1984).
The TDIA has three sequential conditions, each involving cuing (Posner, 1980) and
flanker tasks (Eriksen & Eriksen, 1974). Participants see a series of target arrows flanked by
other arrows and are instructed to press the left or right key that matches the direction of the
center, target arrow. In the flanker task, subjects are presented with a target stimulus, typically an
arrow pointing in one direction or another. Subjects are to push a button corresponding to the
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direction of the target arrow; however, the target arrow is flanked by non-target distractors that
point either in the same direction (in congruent trials) or the opposite direction (in incongruent
trials) as the target. Subjects therefore must ignore the flankers, or control the interference they
present, and maintain their attention on target stimuli. A sample is presented below.

Figure 1. Congruent and incongruent trials in the Eriksen Flanker design (Eriksen & Eriksen,
1974).
The Posner cuing task (Posner, 1980) measures the orienting network of the human
attentional system by presenting a visual cue prior to test stimuli. A percentage of trials has no
visual cue preceding the target and distractor stimuli, while other trials consist of either a center
cue, spatial cue, or invalid cue. A center cue trial involves an asterisk in the center of the
computer screen intended to alert and orient participants that a target stimulus is upcoming;
however, the stimulus may then appear anywhere on the screen. A spatial cue designates that the
target and distractor stimuli appear in the same location as the preceding visual cue (i.e., top,
center, or bottom). An invalid cue indicates that the visual cue and subsequent stimuli appear in
different locations on the screen. The target stimulus for each trial is either congruent or
incongruent with respect to its flanker stimuli, meaning that the target arrow points in the same
or opposing direction as the distractor arrows, respectively.
Condition two builds on condition one by introducing the stop-signal task (Logan, 1981;
Logan & Cowan, 1984). In this task subjects are presented with a stop-signal (i.e., auditory tone)
immediately following a target stimulus, typically within 50-500 milliseconds, signaling to
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subjects to withhold a pre-trained target response. Pairing a target stimulus with a stop-signal
increases the demand for inhibitory control (Schachar et al., 2007). On a percentage of trials, the
tone will sound to signal that the participant should refrain from pressing either arrow keys.
Mean values for MRT and SSRT are calculated for each respondent. MRT represents the mean
reaction time to target stimuli across a designated number of trials and appears as “GO RT
MEAN” in row six of the output spreadsheet. SSRT is calculated by subtracting the ending audio
stop delay from the go reaction time (i.e., MRT – SSD) and appears in row 30 of the output.
Finally, condition three is identical to condition two except that participants are instructed to
ignore the stop-signal and respond to target stimuli as in condition one. Data generated in
condition three were not included in the analysis.
TDIA employs a tracking go-stop method whereby SSD increases by 50ms following
successful response inhibition and decreases by 50ms following unsuccessful response
inhibition. This method produces a desired success rate of about 50% across all trials (Alderson
et al., 2007). After condition three, output is generated using Microsoft Excel software.
Demographics Questionnaire
An English version of a five-item self-report, forced-choice demographics questionnaire
was used to collect clients’ demographic information including their age, sex, psychodiagnostic
history of ADHD, age at time of diagnosis (if applicable), and to ascertain whether they: (1) are
currently prescribed, (2) were previously prescribed, or (3) have never been prescribed
psychostimulant medication.
Procedures
Interested and eligible individuals were recruited using the sampling procedures and
recruitment letters described above (see Appendices A and B). Participants were required to
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appear in-person to complete all measures. For individuals whose participation did not occur in
conjunction with an evaluation in MindFit, 30-minute laboratory sessions were held in preapproved campus locations. Participants were directed to a computer where they were again
presented with the recruitment letter (see Appendix A). As stated in Appendix A, individuals
whose participation did not occur in conjunction with a MindFit evaluation were invited to enter
into an anonymous, random drawing to win one of ten $10 Amazon gift cards. Interested
participants were asked to provide their email addresses for the drawing, and they were informed
that their addresses were not linked to their responses to maintain the anonymity of their data.
Following review of the recruitment letter, participants were directed to an informed
consent document (see Appendix C) where they confirmed their informed consent prior to
accessing the measures. Responses to the demographic questionnaire and ASRS-V1.1 were
stored in a locked filing cabinet maintained by Carruth personnel. Data from the TDIA were
recorded and secured on an external hard drive accessible only to researchers. Participants who
inquired about their performance on any of the measures were advised that no such information
could be provided for the following two reasons: (1) no norms for the TDIA currently exist, and
(2) the study is solely for experimental purposes and is not intended to be clinically informative.
In this case, the examiner was prepared to provide participants with referrals to Carruth for a
clinical assessment of cognitive and/or academic functioning.
Procedures were modified for individuals whose participation occurred concurrent with a
LD/ADHD evaluation in MindFit, in accordance with all agency policies and procedures.
Individuals who were eligible and wished to participate in this study were presented with a
recruitment letter (see Appendix B) and asked to provide their informed consent (see Appendix
C) should they be eligible and wish to participate in this study. Participants were offered a $10
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Amazon gift card in exchange for completing all measures. Responses to the demographic
questionnaire and ASRS-V1.1 were stored in a locked filing cabinet maintained by Carruth
personnel. Data from the TDIA were recorded and secured on an external hard drive accessible
only to researchers.
If a participant in MindFit inquired about their performance on any of the measures, they
were advised that no such information can be provided for the following two reasons: (1) no
norms for the TDIA currently exist, and (2) the study is solely for experimental purposes and is
not intended to be clinically informative. In this case, the examiner was prepared to inform
students that their participation in this study occurred in conjunction with a clinical assessment of
their cognitive and/or academic functioning. Moreover, the examiner informed participants that
their results from study materials were not to be used in any manner nor at any time to make
clinical decisions during their formal evaluation in MindFit.
To identify participants’ datasets and protect their privacy, each participant was assigned
a unique code known only to their attending researcher or MindFit clinician. The coding system
consisted of the examiner’s first and last initial followed by the numerical order in which study
materials were administered to participants (e.g., the fifth participant of examiner “John Smith”
would receive the following code: “JS05”). This code served as each participant’s identification
number and was used to link demographic information to the corresponding dataset.
Finally, all participants were thanked for their time and in cases where participants
experienced any form or level of distress or discomfort related to study participation, they were
referred to professional mental health services. Resources provided included the WVU Carruth
Center for Psychological and Psychiatric Services, the WVU Quin Curtis Center and the WVU
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Student Health Center. Participants were provided with contact information for each resource
(see Appendix F).
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CHAPTER 3: RESULTS
Descriptive Statistics
Data were collected from 49 participants. Technological issues resulted in one
participant’s dataset being deleted; therefore, 48 participants were included in the final sample.
The sample consisted of four participants from the MindFit Clinic at Carruth, seven participants
associated with Kalamazoo College and Western Michigan University, 17 participants from the
Master of Arts in Counseling program at WVU, and 20 participants from WVU’s doctoral
program in Counseling Psychology.
The average age of the sample was 29.75 years, ranging from 19 to 68. Fourteen
participants self-identified as male (29.2%), 32 self-identified as female (66.7%) and two selfidentified as non-binary (4.2%). Five participants (10.4%) had a previous diagnosis of ADHD;
three were diagnosed between the ages of 0-12 years (6.3%), one was diagnosed between 12 and
18 years (2.1%), and one was diagnosed at age 18 years or older (2.1%). Forty-three participants
(89.6%) endorsed never being diagnosed with ADHD. Finally, one participant (2.1%) reported a
current prescription for psychostimulant medication, five participants (10.4%) reported previous
prescriptions, and 42 participants (87.5%) denied a prescription history for psychostimulants.
Descriptive statistics for the measures are provided in Table 1.
Table 1
Descriptive of Measures
Measure
ASRS-V1.1 Total

Min.
9

Max.
53

Mean
26.35

Std. Error
1.49

Std. Deviation
10.33

Variance
106.78

ASRS-V1.1 (I)

5

28

14.46

.77

5.37

28.93

ASRS-V1.1 (H/I)

2

28

11.90

.89

6.18

38.22

TDIA MRT .56332

1.15270

.78711

.02241

.15530

.024

TDIA SSRT .33374

.67446

.44997

.01201

.08326

.007
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A correlation table for the variables is presented in Table 2. The table displays a twotailed probability for each correlation coefficient to identify significant relationships between the
predictor variables. As shown, there is a statistically significant correlation between the two
predictor variables, TDIA MRT and TDIA SSRT; however, a correlation of .499 is below the
threshold for multicollinearity (Laerd Statistics, 2015). Multicollinearity is discussed further in
the section below on assumptions for hierarchical multiple linear regression.
Table 2
Correlations
ASRS-V1.1 ASRS-V1.1 ASRS-V1.1
Total
Inattention (I)
(H/I)
Pearson Correlation
ASRS-V1.1 Total
ASRS-V1.1 (I)
ASRS-V1.1 (H/I)
TDIA MRT
TDIA SSRT
Sig. (2-tailed)
ASRS-V1.1 Total
ASRS-V1.1 (I)
ASRS-V1.1 (H/I)
TDIA MRT
TDIA SSRT

1.000
.877**
.908**
-.274
.194

.877**
1.000
.596**
-.207
.300*
.000

.000
.000
.059
.186

.000
.157
.038

.908**
.596**
1.000
-.278
.063
.000
.000
.056
.669

TDIA
MRT

TDIA
SSRT

-.274
.194
-.207 .300*
-.278
.063
1.000 .499**
.499** 1.000
.059
.157
.056

.186
.038
.669
.000

.000

Note: *p < .05; **p < .01

Assumptions and Reliability of the Measures
Collected data were analyzed to ensure they met six statistical assumptions for
hierarchical multiple linear regression: independence of observations, linearity,
homoscedasticity, multicollinearity, outliers, and multivariate normality (Laerd Statistics, 2015).
There was independence of residuals, as assessed by Durbin-Watson statistics of 1.656 (ASRSV1.1 Total), 2.154 (ASRS-V1.1 Inattention), and 2.263 (ASRS-V1.1 Hyperactivity/Impulsivity).
The assumption of linearity is that a linear relationship exists between the criterion
variable and both predictor variables, collectively and separately. This assumption was tested
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using scatterplots of studentized residuals by unstandardized predicted values and partial
regression plots, respectively. The scatterplots revealed horizontal bands indicating that the
relationships between ASRS-V1.1 Total, ASRS-V1.1 Inattention, ASRS-V1.1
Hyperactivity/Impulsivity, MRT, and SSRT are approximately linear. Partial regression plots
also showed approximately linear relationships between these variables.
Homoscedasticity assumes that the variance of error terms is similar throughout levels of
the predictor variables. This assumption was tested through visual examination of a scatterplot of
studentized residuals versus unstandardized predicted values to determine whether residuals are
randomly and equally distributed across all values of predictor variables. After inspection of the
plots, it was concluded that the assumption of homoscedasticity was not violated.
The assumption of multicollinearity is that the two predictor variables are not highly
correlated with each other at levels above .70 (Laerd Statistics, 2015). Inspection of correlation
coefficients and Tolerance/Variance Inflation Factor (VIF) values revealed no multicollinearity
problems, which arise with Tolerance values less than 0.1 and VIF values greater than 10 (Hair,
Black, Babin, & Anderson, 2014). The Tolerance value for this sample is .751 and the VIF value
is 1.331; therefore, it is unlikely that problems with multicollinearity would have negatively
impacted these results. Regarding unusual data points, no outliers were identified in the casewise
diagnostics table.
Finally, multivariate normality assumes that the variables are normality distributed. This
assumption was tested using a histogram and goodness-of-fit model to assess the shape of the
distribution and identify outliers. The distribution was found to be approximately normal.
In addition to checking assumptions for hierarchical multiple linear regression, each
measure was assessed for internal consistency reliability. Each measure demonstrated a high
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level of internal consistency, as determined by Cronbach’s alpha, based on interpretation
guidelines proposed by George and Mallery (2003). The ASRS-V1.1 Total scores were found to
have a high reliability coefficient (18 items; α = .89). Likewise, scores for the ASRS-V1.1
Inattention subscale demonstrated high internal consistency (9 items; α = .84). Finally, the
ASRS-V1.1 Hyperactivity/Impulsivity subscale scores also demonstrated high internal
consistency (9 items; α = .86). The sample Cronbach’s alpha statistics are provided in Table 3.
Table 3
Internal Consistency Reliability of Measures
Measure

Items Participants Cronbach’s
Internal
N
N
Alpha
Consistency
ASRS-V1.1 Total
18
48
.89
Good
ASRS-V1.1 (I)
9
48
.84
Good
ASRS-V1.1 (H/I)
9
48
.86
Good
Hypothesis Testing
Hypothesis 1
The first hypothesis stated that SSRT will significantly predict ASRS-V1.1 Inattention
scores, over and above MRT alone. A hierarchical multiple regression was conducted to
determine if the addition of SSRT improved the prediction of ASRS-V1.1 Inattention scores,
over and above the proportion of the variance explained by MRT alone. The model included two
continuous predictor variables (i.e., MRT and SSRT) and one continuous criterion variable (i.e.,
ASRS-V1.1 Inattention scores). The full model of MRT and SSRT was statistically significant,
R2 = .259, F(2, 45) = 7.88, p = .001; adjusted R2 = .226. MRT accounted for 4.3% of the
variance in ASRS-V1.1 Inattention scores, a small effect size according to Cohen’s standards
(Cohen, 1988). The addition of SSRT to the prediction of ASRS Inattention led to a statistically
significant increase in R2 of .216, F(1,45) = 13.149, p = .001. SSRT accounted for an additional
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21.6% of the variance in ASRS-V1.1 Inattention scores, which represents a medium effect size
(Cohen, 1988). The results of this analysis are provided in Tables 4 and 5.
Table 4
Model Summary
Model

R

1

.207a

2

.509b

R Square Adjusted Std. Error of R Square F Change DurbinR Square the Estimate Change
Watson
.043
.022
5.319
.043
2.066
.259

.226

4.731

.216

13.149

2.154

a. Predictors: (Constant), MRT
b. Predictors: (Constant), MRT, SSRT
c. Dependent Variable: ASRS-V1.1 Inattention

Table 5
ANOVA
Model

Sum of Squares
1 Regression
58.445
Residual
1301.471
Total
1359.917
2 Regression
352.740
Residual
1007.177
Total
1359.917

df Mean Square
F
Sig.
1
58.445
2.066 .157b
46
28.293
47
2
176.370
7.880 .001c
45
22.382
47

a. Dependent Variable: ASRS-V1.1 Inattention
b. Predictors: (Constant), MRT
c. Predictors: (Constant), MRT, SSRT

Hypothesis 2
The second hypothesis stated that SSRT will significantly predict ASRS-V1.1
Hyperactivity/Impulsivity scores, over and above MRT alone. A hierarchical multiple regression
was conducted to determine if the addition of SSRT improved the prediction of ASRS
Hyperactivity/Impulsivity, over and above the proportion of the variance explained by MRT
alone. The model included two continuous predictor variables (i.e., MRT and SSRT) and one
continuous criterion variable (i.e., ASRS-V1.1 Hyperactivity/Impulsivity scores). The full model
of MRT and SSRT was statistically significant, R2 = .132, F(2, 45) = 3.41, p = .042; adjusted R2
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= .093. MRT accounted for 7.7% of the variance in ASRS-V1.1 Hyperactivity/Impulsivity
scores, which is considered a small effect (Cohen, 1988). The addition of SSRT to the prediction
of ASRS Hyperactivity/Impulsivity led to a statistically significant increase in R2 of .054,
F(1,45) = 2.814, p = .042. SSRT accounted for an additional 5.4% of the variance in ASRS-V1.1
Hyperactivity/Impulsivity scores, which represents a small effect size (Cohen, 1988). The results
of this analysis are provided in Tables 6 and 7.
Table 6
Model Summary
Model

R

1

.278a

2

.363b

R Square Adjusted Std. Error of R Square F Change DurbinR Square the Estimate Change
Watson
.077
.057
6.003
.077
3.853
.132

.093

5.888

.054

2.814

2.263

a. Predictors: (Constant), MRT
b. Predictors: (Constant), MRT, SSRT
c. Dependent Variable: ASRS-V1.1 Hyperactivity/Impulsivity

Table 7
ANOVA
Model
1 Regression
Residual
Total
2 Regression
Residual
Total

Sum of Squares
138.855
1657.624
1796.479
236.415
1560.064
1796.479

df Mean Square
F
Sig.
1
138.855
3.853 .056b
46
36.035
47
2
118.208
3.410 .042c
45
34.668
47

a. Dependent Variable: ASRS-V1.1 Hyperactivity/Impulsivity
b. Predictors: (Constant), MRT
c. Predictors: (Constant), MRT, SSRT

Hypothesis 3
The third hypothesis stated that SSRT will significantly predict ASRS-V1.1 Total scores
(i.e., combined inattention and hyperactivity/impulsivity), over and above MRT alone. A
hierarchical multiple regression was conducted to determine if the addition of SSRT improved
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the prediction of ASRS Total, over and above the proportion of the variance explained by MRT
alone. The model included two continuous predictor variables (i.e., MRT and SSRT) and one
continuous criterion variable (i.e., ASRS-V1.1 Total scores). The full model of MRT and SSRT
was statistically significant, R2 = .221, F(2, 45) = 6.376, p = .004; adjusted R2 = .186. MRT
accounted for 7.5% of the variance in ASRS-V1.1 Total scores, which is a small effect (Cohen,
1988). The addition of SSRT to the prediction of ASRS Total led to a statistically significant
increase in R2 of .146, F(1,45) = 8.408, p = .004. SSRT accounted for an additional 14.6% of the
variance in ASRS-V1.1 Total, which represents a small effect size (Cohen, 1988). The results of
this analysis are provided in Tables 8 and 9.
Table 8
Model Summary
Model

R

1

.274a

2

.470b

R Square Adjusted Std. Error of R Square F Change DurbinR Square the Estimate Change
Watson
.075
.055
10.045
.075
3.741
.221

.186

9.322

.146

8.4808

a. Predictors: (Constant), MRT
b. Predictors: (Constant), MRT, SSRT
c. Dependent Variable: ASRS-V1.1 Total

Table 9
ANOVA
Model

Sum of Squares
1 Regression
377.472
Residual
4641.507
Total
5018.979
2 Regression
1108.215
Residual
3910.764
Total
5018.979

a. Dependent Variable: ASRS-V1.1 Total
b. Predictors: (Constant), MRT
c. Predictors: (Constant), MRT, SSRT

df Mean Square
F
Sig.
1
377.472
3.741 .059b
46
100.902
47
2
554.108
6.376 .004c
45
86.906
47

1.656
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CHAPTER 4: DISCUSSION
Summary of Findings
In this study I evaluated the clinical utility of stop-signal reaction time (SSRT) in the
assessment of attentional processing and response control based on performance on a continuous
performance test (CPT) with central processing demands in a sample of 48 adults aged 19-68
years. The stop-signal task (SST) literature emphasizes CPT in basic “Go / No-Go” tasks (G/NG)
formats without the additional cognitive complexity associated with interference control.
Generally, these studies identify inattention as the predominate feature of ADHD, especially
among children, and emphasize mean reaction time (MRT) and associated metrics as the CPT
parameter of greatest clinical utility when differentiating ADHD and non-ADHD groups. The
current study attempted to replicate and extend the SST literature by examining adults’
performances on a CPT with interference stimuli, thereby demanding greater central processing.
A previous study of adolescents with ADHD showed that, compared to controls, the clinical
group made significantly more omission errors in the presence of distractor stimuli than when no
distractors were presented (Berger & Cassuto, 2014).
The predictor variables in this study were MRT and SSRT (as measured by the TDIA).
The criterion variable(s) was self-reported symptoms of inattention, hyperactivity-impulsivity,
and combined (as measured by the total score and subscales of the ASRS-V1.1). MRT and SSRT
were assessed for their respective predictive significance with three ASRS-V1.1 scales, each of
which corresponds to one of three ADHD diagnostic classifications. Because the literature on
SST does not always indicate which type(s) of ADHD is represented in samples, it was necessary
to assess the predictive significance of SSRT for each ADHD subtype. Three hypotheses were
generated to examine the relationships among these variables.
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First, it was hypothesized that SSRT would significantly predict self-reported symptoms
of inattention, over and above MRT alone. The analysis revealed that SSRT statistically
significantly predicted self-reported symptoms of inattention, over and above MRT alone. The
effect size of SSRT was medium (Cohen, 1988). Second, it was hypothesized that SSRT would
significantly predict self-reported symptoms of hyperactivity/impulsivity, over and above MRT
alone. The analysis revealed that SSRT statistically significantly predicted self-reported
symptoms of hyperactivity/impulsivity, over and above MRT alone. The effect size was small
(Cohen, 1988). Finally, it was hypothesized that SSRT would significantly predict self-reported
combined ADHD symptoms, over and above MRT alone. The analysis revealed that SSRT
statistically significantly predicted combined ADHD symptoms, over and above MRT alone. The
effect size was small (Cohen, 1988).
Overall, these results are consistent with previous research showing the predictive
significance of SSRT in identifying ADHD and non-clinical groups of adults. Lijffijt et al.
(2005) reported a significant difference in SSRT between adults with ADHD and matched
controls. In their study, adult ADHD patients and controls differed significantly on SSRT, and
not MRT, leading researchers to conclude that adult ADHD may be characterized primarily by
deficient inhibitory control, rather than general inattention. Although the current results do not
show that SSRT differentiates between a clinical and control group, the data suggest that SSRT
is significantly predictive of higher or lower ratings of self-reported ADHD symptoms. The
medium effect size for SSRT and self-reported symptoms of inattention that was obtained in this
study is comparable to the medium effect size reported in the Lijffijt et al. (2005) study.
The results of this analysis are consistent with a second study showing the clinical utility
of SSRT in the adult population (Wodushek & Neumann, 2003). A significant, large main effect
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for group (clinically significant versus subthreshold ADHD symptoms) was reported based on
SSRT. Adults with clinically significant self-reported ADHD symptoms exhibited significantly
slower SSRT than individuals with subthreshold symptoms. Although the current study did not
compare between-group SSRT, self-reported ADHD symptoms were significantly predicted by
SSRT. Larger SSRT values (i.e., slower reaction times) significantly predicted higher symptom
ratings for inattentive, hyperactive-impulsive, and combined types of ADHD, whereas smaller
SSRT values (i.e., faster reaction times) were related to lower symptom ratings, after controlling
for MRT.
Second, it was hypothesized that SSRT would significantly predict self-reported
symptoms of hyperactivity/impulsivity, over and above MRT alone. The analysis revealed that
SSRT statistically significantly predicted self-reported symptoms of hyperactivity/impulsivity,
over and above MRT alone. The effect size of SSRT for hyperactivity/impulsivity symptoms was
small (Cohen, 1988). This finding is inconsistent with research by Dinn, Robbins, and Harris
(2001) that examined the CPT performance of 25 adults with ADHD relative to controls. Their
results indicated that performance between groups differed only for adults with Inattentive and
Combined ADHD, not for adults with Hyperactive-Impulsive ADHD. However, because only
four participants in their sample were diagnosed with hyperactive/impulsive ADHD, more
research is needed to confirm whether CPT performance may differ relative to controls for
certain ADHD subtypes and not others. It is important to note that the measure used by Dinn et
al. (2001) involved G/NG tasks without SST and interference conditions. Taken together, these
results indicate that different versions of CPT may vary in the level of sensitivity to specific
ADHD subtypes.
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The ability of SSRT to significantly predict self-reported hyperactive-impulsive
symptoms among adults is noteworthy considering the common course of ADHD throughout the
lifespan. Symptoms of hyperactivity/impulsivity are known to diminish during late adolescence
or early adulthood for most individuals, at which point inattention often becomes preeminent
(APA, 2013). Although adults may still experience hyperactivity or impulsivity, the degree of
functional impairment from these symptoms may decrease due to effective selection of
environments or compensation (Craig, 2011; Jensen et al., 1997; Lasky et al., 2016).
Accordingly, in this sample of adults, the mean score on the ASRS-V1.1 Hyperactive-Impulsive
subscale (11.90) was lower than the mean score on subscales for Inattention (14.46) and
Combined symptoms (26.35).
The composition of this sample of adults may also have contributed to the small, yet
significant effect size of SSRT for hyperactive/impulsive symptoms. Only four participants were
recruited in conjunction with a clinical assessment of ADHD compared to 44 participants who
were recruited through other means. Therefore, only 0.08% of the sample represented clinical
assessment, while 91.6% of the sample consisted of clinical analogues. Adults with hyperactiveimpulsive symptoms may have been largely underrepresented in this sample, both because of the
reliance on analogue assessment and the relatively low prevalence of hyperactive-impulsive
symptoms in the adult population, overall.
Regarding the third hypothesis, SSRT statistically significantly predicted combined
ADHD symptoms, over and above MRT alone. This finding is consistent with previous research
indicating slower SSRT relative to MRT in adults with ADHD combined type compared to
controls (Aron et al., 2003; Bekker et al., 2005; Murphy, 2002). Of note, the effect size for SSRT
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in the current study is small compared to the large effect size reported by Aron et al. (2003). This
is perhaps due to the small sample size included in the current study.
Overall, the results of this study contrasted with previous research on SST that identified
inattention as the key deficit that differentiates ADHD and non-clinical groups among children
and adolescents (Alderson et al., 2007; Oosterlaan et al., 1998). The diversity of results may be
explained by the type of CPT represented in the analyses. Both meta-analyses examined SST
based on G/NG performance without distractors; therefore, there may have been insufficient
cognitive demands to illuminate inhibitory control deficits that may have otherwise existed
between groups. A study of CPT performance with environmental distractors among adolescents
showed that incorporating distractor stimuli aids in identifying an ADHD group (Berger &
Cassuto, 2014). Another explanation for the discrepancy may be that the studies examined CPT
performance among children and adolescents, whereas the current study involved an adult
sample. A meta-analysis of adult patients showed significantly slower SSRT than MRT among
adults, and not among children (Lijffijt et al., 2005).
Based on the predictive significance of SSRT relative to MRT, the current results provide
initial evidence for key inhibitory control deficits among adults with self-reported impairment
from ADHD symptoms. This finding also provides preliminary support for an inhibition deficit
in ADHD (Lipszyc & Schachar, 2010) and the assertion that this deficit is central to ADHD
impairment (Barkley, 1997; Hart et al., 2014) as compared to an underlying attention deficit
(Castellanos & Tannock, 2002). Adults with ADHD may exhibit greater deficits in action
cancellation based on stopping latencies than action initiation when engaged in central
processing. This research also supports the identification of response inhibition deficiency as a
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key ADHD endopehnotype (Aron & Poldrack, 2005; McAuley et al., 2013; Schachar et al.,
2005).
Limitations
While this study may meaningfully contribute to the ADHD and SST literature, it should
be considered preliminary given that there were several limitations. First, based on the current
results, it cannot be confirmed whether all other executive dysfunction associated with ADHD is
secondary to deficits in response inhibition, as Barkley (1997) proposed. While the results show
a greater deficiency in response control (i.e., action cancellation) among adults with higher
ratings of inattentive, hyperactive-impulsive, and combined ADHD symptoms, it remains
unknown to what extent participants’ self-reported impairment is attributable to this facet of
executive dysfunction relative to others. Support for Barkley’s (1997) model is therefore limited
based on the results of this study.
Another limitation of this study is the methodology and the use of analogue assessment.
It is unknown to what extent CPT performance exhibited in this sample represents an appropriate
analogue of CPT performance in clinical settings. Because over 90% of participants in this
sample did not present for clinical assessment, the extent to which these results may be
comparable to studies that differentiate between clinical and non-clinical groups is limited. We
are therefore unable to substantiate previous research suggesting that inhibitory control is
significantly impaired in adults with ADHD relative to a control group (Epstein, Conners,
Sitarenios, & Erhardt, 1998; Lijffijt et al., 2005). In the current study we did not compare mean
SSRT scores between a clinical and control group. Rather, our purpose was to examine the
significance of the association between SSRT scores and self-reported ADHD symptoms, after
controlling for MRT. It remains unknown whether SSRT scores in this sample would allow for
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differentiation between clinically significant and subthreshold impairment, which is essential for
diagnostic purposes.
The generalizability of these results to clinical settings may be limited due to the
relatively low number of participants who were recruited via clinical assessment. Furthermore,
37 of the 49 participants were graduate students, 20 of whom were doctoral students, which is an
unlikely place to find significant signs and symptoms of ADHD given the assumed population
prevalence. The external validity of these results is also limited because the sample was not
randomly selected but rather was selected using convenience sampling methods.
A third limitation of this study is the use of self-reported data to measure ADHD
symptoms. In general, the use of self-report measures presents a limitation because it relies on
participants’ self-report of their experience with and/or perception of the variables of interest,
and therefore may be inaccurate (Heppner et al., 2008). Although self-report measures are often
a core feature in ADHD evaluations (Taylor et al., 2011), research has shown that self-evaluation
of ADHD is prone to underreporting of symptoms (Hoza et al., 2012). It cannot be determined
whether elevations on the ASRS-V1.1 reflect true ADHD symptoms or are artifacts of other
mental health or medical conditions.
A fourth limitation is the potential for the results to have been influenced by different
demand characteristics across participants in the sample. Recall that participants recruited
through MindFit were offered a reward directly, as opposed to a random drawing for other
participants. Participants may have responded differentially depending on which pool they were
in, as the incentive was not the same for all participants.
The use of an instrument that has not yet been empirically validated is another limitation
of this study. The TDIA is a newly constructed G/NG CPT (Donders, 1969) that features three
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cognitive tasks: a modified Posner cuing task (Posner, 1980) that incorporates an Eriksen Flanker
design (Eriksen & Eriksen, 1974) and the classic stop signal paradigm (Logan, 1981; Logan &
Cowan, 1984). The TDIA is an amalgamation of these well-established neuropsychological
tasks, however the current study is the first application of the TDIA to clinical research.
Currently there is no normative sample with which to meaningfully interpret scores. Moreover,
the psychometric properties of the TDIA are presently unknown, thus the results of this study are
preliminary and warrant replication in future research. Despite these limitations, the metrics with
which the TDIA was constructed are well-supported in the literature (Alderson et al., 2007;
Epstein et al., 2001; Lijffijt et al., 2005; Oosterlaan et al., 1998; Wodushek & Neumann, 2003).
Implications
Despite these limitations, the current study has several implications for assessment and
conceptualization of adult ADHD. First, the current study provides initial evidence that
inefficient processing due to generalized attention deficit may not be a predominate feature of
individuals with ADHD, as has been suggested (Alderson et al., 2007; Castellanos & Tannock,
2002; Epstein et al., 2010; Lifffijt et al., 2005; Oosterlaan et al., 1998). Research increasingly
shows that CPT performance by adults with ADHD is distinctive from controls, with inhibitory
control representing a key deficit in the adult clinical population (Aron et al., 2003; Bekker et al.,
2005; Lijffijt et al., 2005; Murphy, 2002; Wodushek & Neumann, 2003). Each of these studies
show significantly slower SSRT among adult ADHD patients compared to controls. Likewise,
the current study demonstrates that SSRT may be a useful metric in the clinical assessment of
adult ADHD. The results are consistent with research showing that cognitive control deficits
associated with motor response inhibition are a core feature of ADHD, with stop-signal
inhibition being proposed as a key characteristic (Aron et al., 2003; Aron & Poldrack, 2005;
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Berger & Cassuto, 2014; Hart et al., 2014; Kofler et al., 2013; McAuley, Crosbie, Charach, &
Schachar, 2013; Schachar et al., 2005; Wodushek & Neumann, 2003). The current study also
supports Barkley’s (1997) conceptual model of ADHD wherein response control deficits are
primary to the executive dysfunction in ADHD.
Second, because this study did not examine CPT performances among children and
adolescents, the data do not address a myriad of studies showing inattention as a primary
characteristic of ADHD in this population (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan
et al., 1998). The implication is that impairment from ADHD symptoms, as measured by CPT
performance, may evolve from childhood to adulthood, with greater indication of attention and
response control deficits at different points throughout the lifespan.
Meta-analyses of SST performance among children with ADHD revealed deficits in
response control and attention, as evidenced by significantly slower SSRT and MRT,
respectively, compared to controls (Alderson et al., 2007; Lijffijt et al., 2005; Losier et al., 1996;
Oosterlaan et al., 1998). A study of adults with ADHD reported similar performance profiles
marked by greater errors of omission and commission relative to controls, suggesting deficits in
both attention and inhibitory control (Epstein et al., 1998). However, it is important to consider
that the studies by Losier et al. (1996) and Epstein et al. (1998) did not involve SST. It is
possible that an alternative CPT, such as one that includes SST, may generate different results
leading to alternate conclusions regarding the course of ADHD. Furthermore, none of the metaanalyses included environmental distractors, thus there were no increased demands for
interference control.
A study by Epstein, Johnson, Varia, and Conners (2001) illustrates how the results of
neuropsychological assessment may vary depending on the type of instrument that is employed.
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A sample of adult ADHD patients was compared to controls on different neuropsychological
tests, one of which was a basic G/NG task while another was a CPT with SST. On the G/NG task
without SST, adult ADHD patients exhibited impulsive responding as evidenced by significantly
more commission errors compared to controls. This finding suggests that adults with ADHD
experience impairment in action restraint, specifically, due to difficulty engaging in the “no-go”
process. Conversely, on the CPT with SST, ADHD patients and controls performed similarly,
suggesting that differentiation of ADHD patients cannot be made based on SST performance.
The conclusion that follows is that action cancellation is not disproportionately impaired among
adult ADHD patients relative to controls. Moreover, it may be concluded that SST is not a useful
metric in the clinical assessment of ADHD in adults. However, the SST task employed in this
study did not involve interference conditions, thus relatively low cognitive processing was
necessary for successful performance. Performance of the clinical group may differ significantly
from controls when greater cognitive processing demands are introduced. The inclusion of
distractor stimuli may also illuminate deficits in action cancellation among adults with ADHD,
whereas the CPT without distractors did not.
Third, due to diversity in measurement and methodology, the literature is mixed as to
whether response inhibition or attention is central to ADHD dysfunction, and relatedly, which
SST metric is most clinically useful in differentiating between ADHD and non-clinical groups.
The current study contributes to the literature in two primary ways. It examined CPT
performance with SST among adults, thereby measuring the action cancellation facet of motor
response inhibition in adulthood (Schachar et al., 2007). This study also included distractor
stimuli, thereby eliciting the need for interference control, which draws upon higher cognitive
processing (Uno et al., 2006; van Velzen et al., 2014). Presently, no study has examined the
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clinical utility of SST in the adult population using a CPT with environmental distractors. The
results of this study are in contrast with the findings of Epstein et al. (2001) by showing that
SSRT is useful in predicting self-reported ADHD symptoms, and by extension, possibly
predicting whose symptoms may reach a diagnostic threshold versus those whose symptoms do
not warrant clinical diagnosis.
Finally, although CPT is commonly used in ADHD evaluations (Munkvold et al., 2014),
numerous studies have shown questionable sensitivity and specificity for ADHD as low
performance is characteristic of a variety of mental health disorders in addition to ADHD
(Advokat et al., 2007; Baggio et al., 2019; Fuermaier et al., 2018; McGee et al., 2000; Tollander,
2011). Likewise, the performance of ADHD patients may not differ significantly from controls,
which renders the instrument minimally useful in clinical settings (Epstein et al., 2001; McGee et
al., 2000). CPT performance is also known to be differentially useful in identifying ADHD
patients depending on examinee age and the type of CPT (Epstein et al., 2001; Lijffijt et al.,
2005). For these reasons, advancement in clinical assessment and diagnosis of ADHD is
contingent upon the development of tests that improve diagnostic accuracy. This study provides
preliminary evidence for the inclusion of SST and environmental distractors in evaluations of
adult ADHD using CPT. The results indicate that this combination of tasks yields greater
predictive significance for identifying individuals with higher ratings of ADHD symptoms based
on SSRT than with MRT alone. Diagnosticians may wish to consider whether a basic G/NG CPT
without SST and environmental distractors is sufficient in identifying adult ADHD patients.
Under these circumstances, clinicians have at their disposal only MRT, which based on the
results of this study, has relatively low predictive power compared to SSRT.
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Future Directions
Several directions for future research on SST may enhance our understanding of adult
ADHD and advance our assessment methods to improve diagnostic accuracy in clinical settings.
Broadly, more research is needed to clarify whether we are defining the pathology of ADHD
correctly. This is especially necessary in light of evidence that CPT scores vary at different
points in the lifespan (Lijffijt et al., 2005). Additionally, future research is needed to replicate
and extend existing studies of SST, many of which show inconsistency in results. The SST
literature will benefit from operationalization of samples and greater consistency in
instrumentation. First, studies have shown that SSRT is useful in differentiating between ADHD
and control groups, yet the composition of clinical groups is often unknown with regard to
ADHD subtype. Because CPT performance may differ by ADHD subtype (Marks et al., 1999), it
is necessary for research on SST to indicate which subtypes are included in analyses of the
clinical utility of SST metrics. Second, Epstein et al. (2001) demonstrated that profiles of CPT
performance may vary between clinical and non-clinical groups when different CPT versions are
used. Conclusions regarding the utility of specific SST metrics are therefore idiosyncratic and
limited in generalizability to all assessment settings.
It will also be important for researchers to continue to validate the TDIA by developing a
normative sample of clinical and non-clinical individuals to identify clinically significant and
subthreshold ranges of performance. This will allow for diagnostic conclusions to be drawn by
comparing an examinee’s performance to the distribution of scores in the normative sample. The
TDIA is presently a newly developed instrument, and this study is the first attempt at preliminary
validation by comparing scores with an existing ADHD measure, albeit one that is self-report.
The results of this study provide compelling evidence for further development of the TDIA for
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assessment of ADHD in the adult population. Future research may examine the utility of the
TDIA in predicting self-reported impairment from ADHD symptoms among children and
adolescents.
One area of future research is to assess the convergent validity of the TDIA and an
existing CPT with satisfactory reliability and validity. The current study demonstrated that TDIA
metrics are significantly correlated with three scales from an existing self-report measure of adult
ADHD symptoms, the ASRS-V1.1 (Kessler et al., 2005). Due to the limitations associated with
self-report measures, it befits TDIA developers to assess the TDIA’s validity in comparison with
a more objective measure of ADHD symptoms, such as the IVA+Plus (Sandford & Turner,
2004). This research would allow for comparison of the TDIA and a CPT with a G/NG format,
which would be useful in replicating the Epstein et al. (2001) results that showed that ADHD and
control groups perform differentially on CPT with and without SST. Furthermore, it will be
important for researchers to assess the clinical utility of the TDIA in comparison with other
CPTs that involve SST, such as the Stop-Signal task (Logan, 1994), which was employed by
Wodushek and Neumann (2003) in their assessment of adult ADHD. Replication and extension
of this study will be necessary to demonstrate that SSRT is slower for adults with ADHD
compared to controls, and to highlight response inhibitory deficits in adults with ADHD based
on stopping latencies. Finally, the TDIA is the only known CPT that includes SST and a Flanker
task (Eriksen & Eriksen, 1974) to measure SSRT amid greater inhibitory control demands
generated by environmental distractors. Research and development of the TDIA will necessitate
that the test be validated alongside similar instruments, should such measures be introduced.
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Conclusion
ADHD is among the most common mental health disorders in adults (APA, 2013). The
goal of the current study was to advance the stop-signal task literature by examining the
relationships between mean reaction time, stop-signal reaction time, and three scales pertaining
to self-reported ADHD symptoms. Examining the predictive significance of these variables
contributed to the SST literature by highlighting the diagnostic utility of SSRT in an adult
sample of clinical analogues and by analyzing a CPT that includes SST and environmental
distractors. It was hypothesized that SSRT would significantly predict self-reported ADHD
symptoms, after statistically controlling for MRT. The results supported this hypothesis for
symptoms of inattention , hyperactivity/impulsivity, and combined symptoms. Future research
examining the clinical utility of SST with more complex CPT methodology may improve clinical
assessment and advance our understanding of ADHD in the adult population.

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

79

REFERENCES
Adler, L. A., Faraone, S. V., Spencer, T. J., Berglund, P., Alperin, S., & Kessler, R. C. (2017).
The structure of adult ADHD. International Journal of Methods in Psychiatric
Research, 26(1), 1-23. doi:10.1002/mpr.1555
Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C., Howes, M. J., Biederman, J., & Secnik,
K. (2006). Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD
symptoms. Annals of Clinical Psychiatry, 18(3), 145-148. doi:
10.1080/1040123060081077
Advokat, C. D., Guidry, D., & Martino, L. (2008). Licit and illicit use of medications for
attention-deficit hyperactivity disorder in undergraduate college students. Journal of
American College Health, 56(6), 601-606. doi: 10.3200/jach.56.6.601-606
Advokat, C. D., Martino, L., Hill, B. D., & Gouvier, W. (2007). Continuous performance test
(CPT) of college students with ADHD, psychiatric disorders, cognitive deficits, or no
diagnosis. Journal of Attention Disorders, 10(3), 253-256. doi:
10.1177/1087054706292106
Agnew-Blais, J. C., Polanczyk, G. V., Danese, A., Wertz, J., Moffitt, T. E., Arseneault, L.
(2016). Evaluation of the persistence, remission, and emergence of attentiondeficit/hyperactivity disorder in young adulthood. Jama Psychiatry, 73(7), 713-20. doi:
10.1001/jamapsychiatry.2016.0465
Alderson, R. M., Rapport, M. D., & Kofler, M. J. (2007). Attention-deficit/hyperactivity disorder
and behavioral inhibition: A meta-analytic review of the stop-signal paradigm. Journal of
Abnormal Child Psychology, 35(5), 745–758. doi: 10.1007/s10802-007-9131-6

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

80

American Psychiatric Association. (1968). Diagnostic and Statistical Manual of Mental
Disorders (2nd ed.). Washington, DC: American Psychiatric Publishing.
American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental
Disorders (3rd ed.). Washington, DC: American Psychiatric Publishing.
American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental
Disorders (3rd ed., text revision). Washington, DC: American Psychiatric Publishing.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental
Disorders (4th ed.). Washington, DC: American Psychiatric Publishing.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders
(5th ed.). Washington, DC.
Anastopoulos, A. D., DuPaul, G. J., Weyandt, L. L., Morrissey-Kane, E., Sommer, J. L., Rhoads,
L. H., … Gudmundsdottir, B. G. (2018). Rates and patterns of comorbidity among firstyear college students with ADHD. Journal of Clinical Child & Adolescent Psychology,
47(2), 236–247. doi: 10.1080/15374416.2015.1105137
Arnett, A. B., Pennington, B. F., Willcutt, E. G., DeFries, J. C., & Olson, R. K. (2014). Sex
differences in ADHD symptom severity. Journal of Child Psychology and Psychiatry,
56(6), 632–639. doi: 10.1111/jcpp.12337
Arnsten, A. F. T. (2009). Toward a new understanding of attention-deficit hyperactivity disorder
pathophysiology. CNS Drugs, 23(1), 33–41. doi: 10.2165/00023210-200923000-00005
Arnsten, A. F. T., & Li, B. M. (2005). Neurobiology of executive functions: Catecholamine
influences on prefrontal cortical functions. Biological Psychiatry, 57(11), 1377-1384.
doi: 10.1016/j.biopsych.2004.08.019

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

81

Aron, A. R., Downson, J. H., Sahakian, B. J., & Robbins, T. W. (2003). Methylphenidate
improves response inhibition in adults with attention-deficit/hyperactivity disorder.
Biological Psychiatry, 54(12), 1465-1468. doi: 10.1016/S0006-3223(03)00609-7
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003). Erratum:
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.
Nature Neuroscience, 6(12), 1329–1329. doi: 10.1038/nn1203-1329a
Aron, A. R., & Poldrack, R. A. (2005). The cognitive neuroscience of response inhibition:
Revelance for genetic research in attention-deficit/hyperactivity disorder. Biological
Psychiatry, 57(11), 1285-1292. doi: 10.1016/j.biopsych.2004.10.026
Asherson, P. (2016). ADHD across the lifespan. Medicine, 44(11), 683–686. doi:
10.1016/j.mpmed.2016.08.012
Aston-Jones, G., & Cohen, J. D. (2005). An integrative theory of locus-coeruleus-norepinephrine
function: Adaptive gain and optimal performance. Annual Review of Neuroscience, 28,
403-450. doi: 10.1146/annurev.neuro.28.061604.135709
Baggio, S., Hasler, R., Giacomini, V., El-Masri, H., Weibel, S., Perroud, N., & Deiber, M.
(2019). Does the continuous performance test predict ADHD symptoms severity and
ADHD presentation in Adults? Journal of Attention Disorders. doi:
10.1177/1087054718822060
Balint, S., Czobor, P., Komlosi, S., Meszaros, A. (2009). Attention deficit hyperactivity disorder
(ADHD): Gender- and age-related differences in neurocognition. Psychological
Medicine, 39(8), 1337-1345. doi: 10.1017/S0033291708004236

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

82

Bari, A., & Robbins, T. W. (2013). Inhibition and impulsivity: Behavioral and neural basis of
response control. Progress in Neurobiology, 108, 44-79. doi:
10.1016/j.pneurobio.2013.06.005
Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions:
Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65-94.
doi:10.1037/0033-2909.121.1.65
Barkley, R. A., & Biederman, J. (1997). Toward a broader definition of the age-of-onset criterion
for attention-deficit hyperactivity disorder. Journal of the American Academy of Child &
Adolescent Psychiatry, 36(9), 1204-1210. doi:10.1097/00004583-199709000-00012
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002). The persistence of attentiondeficit/hyperactivity disorder into young adulthood as a function of reporting source and
definition of disorder. Journal of Abnormal Psychology, 111(2), 279-289.
doi:10.1037/0021-843x.111.2.279
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2004). Young adult follow-up of
hyperactive children: Antisocial activities and drug use. Journal of Child Psychology and
Psychiatry, 45(2), 195–211. doi:10.1111/j.1469-7610.2004.00214.x
Bekker, E. M., Overtoom, C. C., Kenemans, J. L., Kooij, J. J., De Noord, I., Buitelaar, J. K., &
Verbaten, M. N. (2005). Stopping and changing in adults with ADHD. Psychological
Medicine, 35(6), 807-816. doi: 10.1017/S0033291704003459
Benotsch, E. G., Koester, S., Luckman, D., Martin, A. M., & Cejka, A. (2011). Non-medical use
of prescription drugs and sexual risk behavior in young adults. Addictive
Behaviors, 36(1), 152-155. doi:10.1016/j.addbeh.2010.08.027

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

83

Ben-Porath, Y. S. (2013). Self-report inventories: Assessing personality and psychopathology. In
J. R. Graham & J. Naglieri (Eds.), Handbook of psychology (2nd ed. Assessment
psychology (2nd ed.) (Vol. 10, pp. 622–644). New York, NY: Wiley.
Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015). Misuse of stimulant medication
among college students: A comprehensive review and meta-analysis. Clinical Child and
Family Psychology Review, 18(1), 50-76. doi:10.1007/s10567-014-0177-z
Berger, I., & Cassuto, H. (2014). The effect of environmental distractors incorporation into a
CPT on sustained attention and ADHD diagnosis among adolescents. Journal of
Neuroscience Methods, 222, 62-68. doi:10.1016/j.jneumeth.2013.10.012
Beiderman J., & Faraone, S. V. (2005). Attention-deficit hyperactivity disorder. Lancet, 366,
237-248. doi:10.1016/s0140-6736(05)66915-2
Biederman, J., Faraone, S. V., Milberger, S., Guite, J., Mick, E., Chen, L. … Perrin, J. (1996). A
prospective 4-year follow-up study of attention-deficit hyperactivity and related
disorders. Archives of General Psychiatry, 53(5), 437-446.
doi:10.1001/archpsyc.1996.01830050073012
Biederman, J., Faraone, S. V., Monuteaux, M. C., Bober, M., & Cadogen, E. (2004). Gender
effects on attention-deficit/hyperactivity disorder in adults, revisited. Biological
Psychiatry, 55(7), 692-700. doi:10.1016/j.biopsych.2003.12.003
Biederman, J., Kwon, A., Aleardi, M., Chouinard, V.-A., Marino, T., Cole, H., … Faraone, S. V.
(2005). Absence of gender effects on attention deficit hyperactivity disorder: Findings in
nonreferred subjects. American Journal of Psychiatry, 162(6), 1083–1089.
doi:10.1176/appi.ajp.162.6.1083

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

84

Biederman, J., Mick, E., & Faraone, S. V. (2000). Age-dependent decline of symptoms of
attention deficit hyperactivity disorder: Impact of remission definition and symptom type.
The American Journal of Psychiatry, 157(5), 816-818. doi:10.1176/appi.ajp.157.5.816
Biederman, J., Petty, C. R., Evans, M., Small, J., & Faraone, S. (2010). How persistent is
ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry
Research, 177(3), 299-304. doi:10.1016/j.psychres.2009.12.010
Biederman, J., Petty, C. R., Woodworth, Y., Lomedico, A., Hyder, L. L., & Faraone, S. V.
(2012). Adult outcome of attention-deficit/hyperactivity disorder: A controlled 16-year
follow-up study. Journal of Clinical Psychiatry, 73(7), 941-950.
doi:10.4088/jcp.11m07529
Bleck, J., & DeBate, R. D. (2013). Exploring the co-morbidity of attention-deficit/hyperactivity
disorder with eating disorders and disordered eating behaviors in a nationally
representative community-based sample. Eating Behaviors, 14(3), 390–393.
doi:10.1016/j.eatbeh.2013.05.009
Blue Cross Blue Shield Association. (2019). The impact of attention deficit hyperactivity
disorder on the health of America’s children [webpage]. Retrieved from
https://www.bcbs.com/the-health-of-america/reports/impact-of-adhd-attention-deficithyperactivity-disorder-on-health-of-americas-children
Bolino, M. C., Kacmar, K. M., Turnley, W. H., & Gilstrap, J. B. (2008). A multi-level review of
impression management motives and behaviors. Journal of Management, 34(6), 10801109. doi:10.1177/0149206308324325
Borgaro, S., Pogge, D. L., DeLuca, V. A., Bilginer, L., Stokes, J., & Harvey, P. D. (2003).
Convergence of different versions of the continuous performance test: Clinical and

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

85

scientific implications. Journal of Clinical and Experimental Neuropsychology, 25(2),
283-292. doi:10.1076/jcen.25.2.283.13646
Borland, B. L., & Heckman, H. K. (1976). Hyperactive boys and their brothers: A 25-year
follow-up study. Archives of General Psychiatry, 33(6), 669-675.
doi:10.1001/archpsyc.1976.01770060013002
Bornstein, M. H., Jager, J., & Putnick, D. L. (2013). Sampling in developmental science:
Situations, shortcomings, solutions, and standards. Developmental Review, 33(4), 357370. doi: 10.1016/j.dr.2013.08.003
Bron, T. I., Bijlenga, D., Verduijn, J., Penninx, B. W. J. H., Beekman, A. T. F., & Kooij, J. J. S.
(2016). Prevalence of ADHD symptoms across clinical stages of major depressive
disorder. Journal of Affective Disorders, 197, 29–35. doi:10.1016/j.jad.2016.02.053
Bruchmüller, K., Margraf, J., & Schneider, S. (2012). Is ADHD diagnosed in accord with
diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. Journal of
Consulting and Clinical Psychology, 80(1), 128–138. doi:10.1037/a0026582
Bruner, M. R., Kuryluk, A. D., & Whitton, S. W. (2015). Attention-deficit/hyperactivity disorder
symptom levels and romantic relationship quality in college students. Journal of
American College Health, 63(2), 98–108. doi:10.1080/07448481.2014.975717
Bryant, A. M., Lee, E., Howell, A., Morgan, B., Cook, C. M., Patel, K., … Suhr, J. A. (2018).
The vulnerability of self-reported disability measures to malingering: A simulated ADHD
study. The Clinical Neuropsychologist, 32(1), 1-10. doi:10.1080/13854046.2017.1346145
Bush, G., Valera, E. M., & Seidman, L. J. (2005). Functional neuroimaging of attentiondeficit/hyperactivity disorder: A review and suggested future directions. Biological
Psychiatry, 57(11), 1273–1284. doi:10.1016/j.biopsych.2005.01.034

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

86

Cadman, T., Findon, J., Eklund, H., Hayward, H., Howley, D., Cheung, C., … Asherson, P.
(2016). Six-year follow-up study of combined type ADHD from childhood to young
adulthood: Predictors of functional impairment and comorbid symptoms. European
Psychiatry, 35, 47–54. doi:10.1016/j.eurpsy.2015.08.007
Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the
multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81-105.
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006). Characterizing
cognition in ADHD: Beyond executive dysfunction. Trends in Cognitive Sciences, 10(3),
117-123. doi: 10.1016/j.tics.2006.01.011
Castellanos, F. X., & Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity
disorder: The search for endophenotypes. Nature Review Neuroscience, 3, 617-628. doi:
10.1038/nrn896
Caye, A., Rocha, T. B.-M., Anselmi, L., Murray, J., Menezes, A. M. B., Barros, F. C., … Rohde,
L. A. (2016). Attention-deficit/hyperactivity disorder trajectories from childhood to
young adulthood. JAMA Psychiatry, 73(7), 705-712.
doi:10.1001/jamapsychiatry.2016.0383
Chen, M. H., Pan, T. L., Hsu, J. W., Huang, K. L., Su, T. P., Li, C. T., … Bai, Y. M. (2016).
Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among
patients with major depression: A nationwide longitudinal study. European
Neuropsychopharmacology, 26(11), 1760–1767. doi:10.1016/j.euroneuro.2016.09.369
Christakis, D. A., Zimmerman, F. J., DiGiuseppe, D. L., & McCarty, C. A. (2004). Early
television exposure and subsequent attentional problems in children. Pediatrics, 113,
708-713. doi:10.1542/peds.113.4.708

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

87

Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd Edition. Erlbaum,
Hillsdale, NJ.
Conners, C. K. (1995). Conners’ Continuous Performance Test. Toronto: Multi-Health Systems.
Conners, C. K. (2000). CPT-II: Continuous Performance Test II: Computer program for
Windows technical guide and software manual. Toronto, ON: Multi-Health Systems.
Connor, D. F., Steeber, J., & McBurnett, K. (2010). A review of attention-deficit/hyperactivity
disorder complicated by symptoms of oppositional defiant disorder or conduct disorder.
Journal of Developmental and Behavioral Pediatrics, 31, 427-440. doi:
10.1097/DBP.0b013e3181e121bd
Constantinou, M., Bauer, L., Ashendorf, L., Fisher, J. M., & McCaffrey, R. J. (2005). Is poor
performance on recognition memory effort measures indicative of generalized poor
performance on neuropsychological tests? Archives of Clinical Neuropsychology, 20(2),
191-198. doi:10.1016/j.acn.2004.06.002
Craig, W. S. (2011). Adult attention deficit hyperactivity disorder. Journal of Men’s Health,
8(4), 299–305. doi:10.1016/j.jomh.2011.08.001
Crowne, D. P., & Marlowe, D. (1960). A new scale of social desirability independent of
psychopathology. Journal of Consulting Psychology, 24(4), 349-354.
doi:10.1037/h0047358
Cruz, S., Sumstine, S., Mendez, J., & Bavarian, N. (2017). Health-compromising practices of
undergraduate college students: Examining racial/ethnic and gender differences in
characteristics of prescription stimulant misuse. Addictive Behaviors, 68, 59-65.
doi:10.1016/j.addbeh.2017.01.016

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

88

Cubillo, A., & Rubia, K. (2010). Structural and functional brain imaging in adult attentiondeficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 10(4), 603-620.
doi:10.1586/ern.10.4
Cuffe, S. P., Moore, C. G., & McKeown, R. E. (2005). Prevalence and correlates of ADHD
symptoms in the national health interview survey. Journal of Attention Disorders, 9(2),
392-401. doi:10.1177/1087054705280413
Dalsgaard, S., Østergaard, S. D., Leckman, J. F., Mortensen, P. B., & Pedersen, M. G. (2015).
Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder:
A nationwide cohort study. The Lancet, 385(9983), 2190-2196. doi:10.1016/s01406736(14)61684-6
Dambacher, F., Sack, A. T., Lobbestael, J., Arntz, A., Brugman, S., & Schuhmann, T. (2014). A
network approach to response inhibition: Dissociating functional connectivity of neural
components involved in action restraint and action cancellation. European Journal of
Neuroscience, 39(5), 821-831. doi:10.1111/ejn.12425
Davidson, M. C., & Marrocco, R. T. (2000). Local infusion of scopolamine into intraparietal
cortex slows covert orienting in rhesus monkeys. Journal of Neurophysiology, 83(3),
1536-1549. doi: 10.1152/jn.2000.83.3.1536
DeGutis, J. M., & Van Vleet, T. M. (2010). Tonic and phasic alertness training: A novel
behavioral therapy to improve spatial and non-spatial attention in patients with
hemispatial neglect. Frontiers in Human Neuroscience, 4(60), 1-17. doi:
10.3389/fnhum.2010.00060
Demontis, D., Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., … & Neale, B.
M. (2019). Discovery of the first genome-wide significant risk loci for attention

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

89

deficit/hyperactivity disorder. Cardiff University. Nature Genetics, 51(1), 63-75. doi:
10.1038/s41588-018-0269-7
Diener, M. B., & Milich, R. (1997). Effects of positive feedback on the social interactions of
boys with attention deficit hyperactivity disorder: A test of the self-protective
hypothesis. Journal of Clinical Child Psychology, 26(3), 256-265.
doi:10.1207/s15374424jccp2603_4
Dinn, W. M., Robbins, N. C., & Harris, C. L. (2001). Adult attention-deficit/hyperactivity
disorder: Neuropsychological correlates and clinical presentation. Brain and Cognition,
46(1-2), 114-121. doi: 10.1016/S0278-2626(01)80046-4
Donders, F. C. (1969). On the speed of mental processes. Acta psychologica, 30, 412-431.
doi:10.1016/0001-6918(69)90065-1
Dosenbach, N. U. F., Fair, D. A., Cohen, A. L., Schlaggar, B. L., & Petersen, S. E. (2008). A
dual-networks architecture of top-down control. Trends in Cognitive Neuroscience, 12(3),
99-105. doi: 10.1016/j.tics.2008.01.001
Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., … &
Neumann, P. J. (2012). Economic impact of childhood and adult attentiondeficit/hyperactivity disorder in the United States. Journal of the American Academy of
Child & Adolescent Psychiatry, 51(10), 990-1002. doi:10.1016/j.jaac.2012.07.008
Douglas, V. I. (1972). Stop, look and listen: The problem of sustained attention and impulse
control in hyperactive and normal children. Canadian Journal of Behavioural
Science, 4(4), 259-282. doi:10.1037/h0082313

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

90

DuPaul, G. J., Gormley, M. J., & Laracy, S. D. (2013). Comorbidity of LD and ADHD:
Implications of DSM-5 for assessment and treatment. Journal of Learning
Disabilities, 46(1), 43-51. doi:10.1177/0022219412464351
DuPaul, G. J., Power, T. J., Anastopoulos, A. D. & Reid, R. (1998). ADHD rating scale-IV:
Checklists, norms, and clinical Interpretation. New York, NY: Guilford.
DuPont, R. L., Coleman, J. J., Bucher, R. H., & Wilford, B. B. (2008). Characteristics and
motives of college students who engage in nonmedical use of methylphenidate. The
American Journal on Addictions, 17(3), 167-171. doi:10.1080/10550490802019642
Edwards, M. C., Gardner, E. S., Chelonis, J. J., Schulz, E. G., Flake, R. A., & Diaz, P. F. (2007).
Estimates of the validity and utility of the Conners’ continuous performance test in the
assessment of inattentive and/or hyperactive-impulsive behaviors in children. Journal of
Abnormal Child Psychology, 35(3), 393-404. doi:10.1007/s10802-007-9098-3
Efron, D. (2015). Attention-deficit/hyperactivity disorder: The past 50 years. Journal of
Pediatrics and Child Health, 51(1), 69-73. doi:10.1111/jpc.12809
Egan, K. L., Reboussin, B. A., Blocker, J. N., Wolfson, M., & Sutfin, E. L. (2013). Simultaneous
use of non-medical ADHD prescription stimulants and alcohol among undergraduate
students. Drug and Alcohol Dependence, 131(1), 71-77.
doi:10.1016/j.drugalcdep.2012.12.004
Egeland, J., Johansen, S. N., & Ueland, T. (2009). Differentiating between ADHD sub-types on
CCPT measures of sustained attention and vigilance. Scandinavian Journal of
Psychology, 50(4), 347-354. doi:10.1111/j.1467-9450.2009.00717.x

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

91

Elder, T. (2010). The importance of relative standards in ADHD diagnoses: Evidence based on
exact birth dates. Journal of Health Economics, 29(5), 641-641.
doi:10.1016/j.jhealeco.2010.06.003
Elder, T., & Lubotsky, D. (2009). Kindergarten entrance age and children's achievement:
Impacts of state policies, family background, and peers. Journal of Human
Resources, 44(3), 641-683. doi:10.3368/jhr.44.3.641
Epstein, J. N., Conners, C. K., Sitarenios, G., & Erhardt, D. (1998). Continuous performance test
results of adults with attention deficit hyperactivity disorder. The Clinical
Neuropsychologist, 12(2), 155-168. doi: 10.1076/clin.12.2.155.2000
Epstein, J. N., Erkanli, A., Conners, C. K., Klaric, J., Costello, J. E., & Angold, A. (2003).
Relations between continuous performance test performance measures and ADHD
behaviors. Journal of Abnormal Child Psychology, 31(5), 543-554.
doi:10.1023/a:1025405216339
Epstein, J. N., Hwang, M. E., Antonini, T., Langberg, J. M., Altaye, M., & Arnold, L. E. (2010).
Examining predictors of reaction times in children with ADHD and normal
controls. Journal of the International Neuropsychological Society, 16(1), 138-147.
doi:10.1017/s1355617709991111
Epstein, J. N., Johnson, D. E., Varia, I. M., & Conners, C. K. (2001). Neuropsychological
assessment of response inhibition in adults with ADHD. Journal of Clinical and
Experimental Neuropsychology, 23(3), 362-371. doi: 10.1076/jcen.23.3.362.1186
Eriksen, B. A., & Eriksen, C. W. (1974). Effects of noise letters upon the identification of a
target letter in a nonsearch task. Perception & Psychophysics, 16(1), 143-149.
doi:10.3758/bf03203267

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

92

Estévez, N., Dey, M., Eich-Höchli, D., Foster, S., Gmel, G., & Mohler-Kuo, M. (2016). Adult
attention-deficit/hyperactivity disorder and its association with substance use and
substance use disorders in young men. Epidemiology and Psychiatric Sciences, 25(03),
255–266. doi:10.1017/s2045796015000360
Etikan, I., Musa, S. A., & Alkassim, R. S. (2016). Comparison of convenience sampling and
purposive sampling. The American Journal of Theoretical and Applied Statistics, 5(1), 14. doi: 10.11648/j.ajtas.2016-9006
Evans, W., Morrill, M., & Parente, S. (2010). Measuring inappropriate medical diagnosis and
treatment in survey data: The case of ADHD among school-age children. Journal of
Health Economics, 29(5), 657-657. doi:10.1016/j.jhealeco.2010.07.005
Faraone, S. V., Biederman, J., & Mick, E. (2006). The age-dependent decline of attention deficit
hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36,
159-165. doi:10.1017/s003329170500471x
Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., & Doyle, A. E.
(2000). Attention-deficit/hyperactivity disorder in adults: An overview. Biological
Psychiatry, 48(1), 9-20. doi:10.1016/s0006-3223(00)00889-1
Faraone, S. V., & Mick, E. (2010). Molecular genetics of attention deficit hyperactivity disorder.
Psychiatric Clinics of North America, 33(1), 159–180. doi:10.1016/j.psc.2009.12.004
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., &
Sklar, P. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological
Psychiatry, 57, 1313-1323. doi:10.1016/j.biopsych.2004.11.024

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

93

Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical power analyses using G*
Power 3.1: Tests for correlation and regression analyses. Behavior Research
Methods, 41(4), 1149-1160. doi:10.3758/brm.41.4.1149
Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., ... Jin, R.
(2007). Cross-national prevalence and correlates of adult attention-deficit hyperactivity
disorder. British Journal of Psychiatry, 190, 402–409. doi:10.1192/bjp.bp.106.034389
Fisher, A. B., & Watkins, M. W. (2008). ADHD rating scales’ susceptibility to faking in a
college student sample. Journal of Postsecondary Education and Disability, 20(2), 81–
92.
Flory, K., Molina, B. S., Pelham, W. E., Gnagy, E., & Smith, B. (2006). Childhood ADHD
predicts risky sexual behavior in young adulthood. Journal of Clinical Child and
Adolescent Psychology, 35(4), 571-577. doi: 10.1207/s15374424jccp3504
Frances, A. J., & Widiger, T. (2012). Psychiatric diagnosis: Lessons from the DSM-IV past and
cautions for the DSM-5 future. Annual Review of Clinical Psychology, 8, 109-130.
doi:10.1146/annurev-clinpsy-032511-143102
Froehlich, T. E., Anixt, J. S., Loe, I. M., Chirdkiatgumchai, V., Kuan, L., & Gilman, R. C.
(2011). Update on environmental risk factors for attention-deficit/hyperactivity disorder.
Current Psychiatry Reports, 13, 333-344. doi:10.1007/s11920-011-0221-3
Fuermaier, A. B., Fricke, J. A., de Vries, S. M., Tucha, L., & Tucha, O. (2018).
Neuropsychological assessment of adults with ADHD: A delphi consensus study. Applied
Neuropsychology: Adult, 1-15. doi:10.1080/23279095.2018.1429441

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

94

Gallucci, A. R., Martin, R. J., & Usdan, S. L. (2015). The diversion of stimulant medications
among a convenience sample of college students with current prescriptions. Psychology
of Addictive Behaviors, 29(1), 154-161. doi:10.1037/adb0000012
Garfield, C. F., Dorsey, E. R., Zhu, S., Huskamp, H. A., Conti, R., Dusetzina, S. B., … &
Alexander, C. G. (2012). Trends in attention deficit hyperactivity disorder ambulatory
diagnosis and medical treatment in the United States, 2000-2010. Academic Pediatrics,
12(2), 110-116. doi:10.1016/j.acap.2012.01.003
Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010). Attention-deficit/hyperactivity
disorder and the dopaminergic hypotheses. Expert Review of Neurotherapeutics, 10(4),
587–601. doi:10.1586/ern.10.17
George, D., & Mallery, P. (2003). SPSS for Windows step by step: A simple guide and reference
(4th ed.). Boston, MA: Allyn & Bacon.
Gilberg, C., Gilberg, I. C., Rasmussen, P., Kadesjo, B., Soderstrom, H., Rastam, M., …
Niklasson, L. (2004). Co-existing disorders in ADHD – implications for diagnosis and
intervention. European Child and Adolescent Psychiatry, 13, 80-92. doi:
10.1007/s00787-0041008-4
Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014). Underdiagnosis
of attention-deficit/hyperactivity disorder in adult patients: A review of the literature. The
Primary Care Companion for CNS Disorders, 16(3). doi:10.4088/pcc.13r01600
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009). Candidate gene studies of ADHD: A metaanalytic review. Human Genetics, 126, 51-90. doi:10.1007/s00439-009-0694-x
Gray, J. A. (1987). The psychology of fear and stress (2nd ed.). Cambridge: Cambridge
University Press.

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

95

Gray, S., Woltering, S., Mawjee, K., & Tannock, R. (2014). The adult ADHD self-report scale
(ASRS): Utility in college students with attention-deficit/hyperactivity disorder. PeerJ,
2(324), 1-17. doi:10.7717/peerj.324
Green, P. (2008). Medical symptom validity test for windows: User’s manual and
program. Edmonton, Canada: Green’s Publishing.
Greenberg, L. M., & Waldman, I. D. (1993). Developmental normative data on the test of
variables of attention (TOVA). Child Psychology & Psychiatry & Allied Disciplines, 34
(6), 1019-1030. doi:10.1111/j.1469-7610.1993.tb01105.x
Guelzow, B., Loya, F., & Hinshaw, S. (2017). How persistent is ADHD into adulthood?
Informant report and diagnostic thresholds in a female sample. Journal of Abnormal
Child Psychology, 45(2), 301-312. doi:10.1007/s10802-016-0174-4
Guo, Y., Schmitz, T. W., Mur, M., Ferreira, C. S., & Anderson, M. C. (2018). A supramodal role
of the basal ganglia in memory and motor inhibition: Meta-analytic evidence.
Neuropsychologia, 108, 117-134. doi: 10.1016/j.neuropsychologia.2017.11.033
Hair, J. F., Black, W. C., Babin, B. J., & Anderson, R. E. (2014). Multivariate data analysis (7th
ed.). Essex, UK: Pearson.
Harrison, A. G., Edwards, M. J., & Parker, K. C. (2007). Identifying students faking ADHD:
Preliminary findings and strategies for detection. Archives of Clinical
Neuropsychology, 22(5), 577-588. doi:10.1016/j.acn.2007.03.008
Hart, H., Chantiluke, K., Cubillo, A. I., Smith, A. B., Simmons, A., Brammer, M. J., … & Rubia,
K. (2014). Pattern classification of response inhibition in ADHD: Toward the
development of neurobiological markers for ADHD. Human Brain Mapping, 35, 30833094. doi:10.1002/hbm.22386

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

96

Hassan, E. (2006). Recall bias can be a threat to retrospective and prospective research
designs. The Internet Journal of Epidemiology, 3(2), 339-412. doi:10.5580/2732
Hedges, L. V. (1982). Estimation of effect sizes from a series of independent experiments.
Psychological Bulletin, 92, 490-499. doi: 10.1037/0033-2909.92.2.490
Henry, B., Moffitt, T. E., Caspi, A., Langley, J., & Silva, P. A. (1994). On the "remembrance of
things past": A longitudinal evaluation of the retrospective method. Psychological
Assessment, 6(2), 92-101. doi:10.1037/1040-3590.6.2.92
Heppner, P. P., Wampold, B. E., & Kivlighan, D. M. (2008). Quantitative descriptive
designs. Research Designs in Counseling, 3, 224-255.
Hoza, B., Vaughn, A., Waschbusch, D. A., Murray-Close, D., & McCabe, G. (2012). Can
children with ADHD be motivated to reduce bias in self-reports of competence? Journal
of Consulting and Clinical Psychology, 80(2), 245-254. doi:10.1037/a0027299
Huang, C. Y., Liao, H. Y., & Chang, S. H. (1998). Social desirability and the clinical self-report
inventory: Methodological reconsideration. Journal of Clinical Psychology, 54(4), 517528. doi: 10.1002/(SICI)1097-4679(199806)54:4<517::AID-JCLP13>3.0.CO;2-I
Huang-Pollock, C. L., Karalunas, S. L., Tam, H., & Moore, A. N. (2012). Evaluating vigilance
deficits in ADHD: A meta-analysis of CPT performance. Journal of Abnormal
Psychology, 121(2), 360-371. doi:10.1037/a0027205
Instanes, J. T., Klungsøyr, K., Halmøy, A., Fasmer, O. B., & Haavik, J. (2016). Adult ADHD
and comorbid somatic disease: A systematic literature review. Journal of Attention
Disorders, 22(3), 203–228. doi:10.1177/1087054716669589

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

97

Jachimowicz, G., & Geiselman, R. E. (2004). Comparison of ease of falsification of attention
deficit hyperactivity disorder diagnosis using standard behavioral rating scales. Cognitive
Science Online, 2(1), 6-20.
Jensen, P. S., Mrazek, D., Knapp, P. K., Steinberg, L., Pfeffer, C., Schowalter, J., & Shapiro, T.
(1997). Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation.
Journal of the American Academy of Child & Adolescent Psychiatry, 36(12), 1672–1681.
doi:10.1097/00004583-199712000-00015
Kaisari, P., Dourish, C. T., & Higgs, S. (2017). Attention deficit hyperactivity disorder (ADHD)
and disordered eating behavior: A systematic review and a framework for future research.
Clinical Psychology Review, 53, 109–121. doi:10.1016/j.cpr.2017.03.002
Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E. V. A., ... & Ustun, T. B.
(2005). The world health organization adult ADHD self-report scale (ASRS): A short
screening scale for use in the general population. Psychological Medicine, 35(2), 245256. doi:10.1017/s0033291704002892
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., ... & Spencer,
T. (2006). The prevalence and correlates of adult ADHD in the United States: Results
from the national comorbidity survey replication. American Journal of
Psychiatry, 163(4), 716-723. doi:10.1176/ajp.2006.163.4.716
King, M. F., & Bruner, G. C. (2000). Social desirability bias: A neglected aspect of validity
testing. Psychology & Marketing, 17(2), 79-103. doi: 10.1002/(SICI)15206793(200002)17:2<79::AID-MAR2>3.0.CO;2-0
Klein, R. G., Mannuzza, S., Olazagasti, M. A. R., Roizen, E., Hutchison, J. A., Lashua, E. C., &
Castellanos, F. X. (2012). Clinical and functional outcome of childhood attention-

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

98

deficit/hyperactivity disorder 33 years later. Archives of General Psychiatry, 69(12),
1295-1303. doi:10.1001/archgenpsychiatry.2012.271
Knouse, L. E., Bagwell, C. L., Barkley, R. A., & Murphy, K. R. (2005). Accuracy of selfevaluation in adults with ADHD: Evidence from a driving study. Journal of Attention
Disorders, 8(4), 221-234. doi:10.1177/1087054705280159
Kofler, M. J., Rapport, M. D., Sarver, D. E., Raiker, J. S., Orban, S. A., Friedman, L. M., &
Kolomeyer, E. G. (2013). Reaction time variability in ADHD: A meta-analytic review of
319 studies. Clinical Psychology Review, 33(6), 795-811. doi:10.1016/j.cpr.2013.06.001
Kofman, O., Larson, J. G., & Mostofsky, S. H. (2008). A novel task for examining strategic
planning: Evidence for impairment in children with ADHD. Journal of Clinical and
Experimental Neuropsychology, 30(3), 261-271. doi:10.1080/13803390701380583
Kooij, J. J. S., Boonstra, A. M., Swinkels, S.H.N., Bekker, E. M., de Noord, I., & Buitelaar, K.
(2008). Reliability, validity, and utility of instruments of self-report and informant report
concerning symptoms of ADHD in adult patients. Journal of Attention Disorders, 11(4),
445-458. doi:10.1177/1087054707299367
Laerd Statistics. (2015). Hierarchical multiple regression using SPSS Statistics [webpage].
Retrieved from https://statistics.laerd.com/
LaLonde Jr, D. G. (2013). Effects of media exposure on intention to seek mental health treatment
in college students. (Doctoral dissertation, Indiana University of Pennsylvania).
Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical
data. Biometrics, 159-174. doi:10.2307/2529310
Langley, K., Fowler, T., Ford, T., Thapar, A. K., van den Bree, M., Harold, G., … Thapar, A.
(2010). Adolescent clinical outcomes for young people with attention-deficit

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

99

hyperactivity disorder. The British Journal of Psychiatry, 196, 235-240. doi:
10.1192/bjp.bp.109.066274
Lasky, A. K., Weisner, T. S., Jensen, P. S., Hinshaw, S. P., Hechtman, L., Arnold, L. E., …
Swanson, J. M. (2016). ADHD in context: Young adults’ reports of the impact of
occupational environment on the manifestation of ADHD. Social Science & Medicine,
161, 160–168. doi:10.1016/j.socscimed.2016.06.003
Layton, T. J., Barnett, M. L., Hicks, T. R., & Jena, A. B. (2018). Attention deficit-hyperactivity
disorder and month of school enrollment. New England Journal of Medicine, 379, 21222130. doi: 10.1056/NEJMoa1806828
Leber, A. B., Turk-Browne, N. B., & Chun, M. M. (2008). Neural predictors of moment-tomoment fluctuations in cognitive flexibility. PNAS, 105(36), 13592-13597. doi:
10.1073/pnas.0805423105
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011). Prospective association of
childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and
abuse/dependence: A meta analytic review. Clinical Psychology Review, 31, 328-341.
doi: 10.1016/j.cpr.2011.01.006
Lenzi, F., Cortese, S., Harris, J., & Masi, G. (2018). Pharmacotherapy of emotional
dysregulation in adults with ADHD: A systematic review and meta-analysis.
Neuroscience & Biobehavioral Reviews, 84, 359–367.
doi:10.1016/j.neubiorev.2017.08.010
Leppma, M., Long, D., Smith, M., & Lassiter, C. (2017). Detecting symptom exaggeration in
college students seeking ADHD treatment: Performance validity assessment using the

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

100

NV-MSVT and IVA-Plus. Applied Neuropsychology: Adult, 25(3), 210–218.
doi:10.1080/23279095.2016.1277723
Levin, R. L., & Rawana, J. S. (2016). Attention-deficit/hyperactivity disorder and eating
disorders across the lifespan: A systematic review of the literature. Clinical Psychology
Review, 50, 22–36. doi:10.1016/j.cpr.2016.09.010
Levy, F. (1991). The dopamine theory of attention deficit hyperactivity disorder (ADHD).
Australian & New Zealand Journal of Psychiatry, 25(2), 277-283. doi:
10.3109/00048679109077746
Lijffijt, M., Kenemans, J. L., Verbaten, M. N., & van Engeland, H. (2005). A meta-analytic
review of stopping performance in attention-deficit/hyperactivity disorder: Deficient
inhibitory motor control? Journal of Abnormal Psychology, 114(2), 216-222.
doi:10.1037/0021-843x.114.2.216
Lipsey, M. W., & Wilson, D. B. (2000). Practical meta-analysis. Thousand Oaks, CA: Sage.
Lipszyc, J., & Schachar, R. (2010). Inhibitory control and psychopathology: A meta-analysis of
studies using the stop signal task. Journal of the International Neuropsychological
Society, 16(6), 1064-1076. doi: 10.1017/S135561770000895
Logan, G. D. (1981). Attention, automaticity, and the ability to stop a speeded choice
response. Attention and Performance, 4, 205-222.
Logan, G. D. (1994). On the ability to inhibit thought and action: A users' guide to the stop
signal paradigm. In D. Dagenbach & T. H. Carr (Eds.), Inhibitory processes in attention,
memory, and language (pp. 189-239). San Diego, CA: Academic Press.
Logan, G. D., & Cowan, W. B. (1984). On the ability to inhibit thought and action: A theory of
an act of control. Psychological Review, 91(3), 295-327. doi:10.1037/0033-295x.91.3.295

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

101

Logan, G. D., Schachar, R. J., & Tannock, R. (1997). Impulsivity and inhibitory control.
Psychological Science, 8(1), 60–64. doi:10.1111/j.1467-9280.1997.tb00545.x
London, A. S., & Landes, S. D. (2016). Attention deficit hyperactivity disorder and adult
mortality. Preventive Medicine, 90, 8-10. doi:10.1016/j.ypmed.2016.06.021
Long, D. G. (2018). Test of differential inhibition and attention. Manuscript in preparation.
Lopez, R., Micoulaud-Franchi, J.-A., Galera, C., & Dauvilliers, Y. (2017). Is adult-onset
attention deficit/hyperactivity disorder frequent in clinical practice? Psychiatry Research,
257, 238–241. doi:10.1016/j.psychres.2017.07.080
Losier, B. J., McGrath, P. J., & Klein, R. M. (1996). Error patterns on the continuous
performance test in non-medicated and medicated samples of children with and without
ADHD: A meta-analytic review. Journal of Child Psychology and Psychiatry, 37(8),
971-987. doi:10.1111/j.1469-7610.1996.tb01494.x
Mackworth, J. F., & Taylor, M. M. (1963). The d'measure of signal detectability in vigilance like
situations. Canadian Journal of Psychology/Revue Canadienne de Psychologie, 17(3),
302-325. doi: 10.1037/h0092885
MacLeod, C. M. (1992). The Stroop task: The "gold standard" of attentional measures. Journal
of Experimental Psychology: General, 121(1), 12-14. doi:10.1037/0096-3445.121.1.12
Magnin, E., & Maurs, C. (2017). Attention-deficit/hyperactivity disorder during adulthood.
Revue Neurologique, 173(7), 506–515. doi:10.1016/j.neurol.2017.07.008
Mallett, C. A., Natarajan, A., & Hoy, J. (2014). Attention deficit/hyperactivity disorder: A DSM
timeline review. International Journal of Mental Health, 43, 36-60.
doi:10.1080/00207411.2015.1009310

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

102

Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1998). Adult outcome of
hyperactive boys. Archives of General Psychiatry, 50(7), 565-576.
doi:10.1176/ajp.155.4.493
Marks, D. J., Himelstein, J., Newcorn, J. H., & Halperin, J. M. (1999). Identification of AD/HD
subtypes using laboratory-based measures: A cluster analysis. Journal of Abnormal Child
Psychology, 27(2), 167-175.
Martinuessen, R., Hayden, J., Hogg-Johnson, S., & Tannock, R. (2005). A meta-analysis of
working memory impairments in children with attention-deficit/hyperactivity disorder.
Journal of the American Academic of Child & Adolescent Psychiatry, 44(4), 377-384.
doi:10.1097/01.chi.0000153228.72591.73
Matte, B., Rohde, L. A., Turner, J. B., Fisher, P. W., Shen, S., Bau, C., … & Grevet, E. H.
(2015). Reliability and validity of proposed DSM-5 ADHD symptoms in a clinical
sample of adults. The Journal of Neuropsychiatry and Clinical Neurosciences, 27(3),
228-236. doi:10.1176/appi.neuropsych.13060137
McAuley, T., Crosbie, J., Charach, A., & Schachar, R. (2013). The persistence of cognitive
deficits in remitted and unremitted ADHD: A case for the state-independence of response
inhibition. Journal of Child Psychology and Psychiatry, 55(3), 292-300. doi:
10.1111/jcpp.12160
McCluskey, D. L. (2017). Examining the efficacy of a 1-session brief behavioral activation
intervention with university students with mild to moderate depressive symptoms.
(Doctoral dissertation, West Virginia University).
McGee, R. A., Clark, S. E., & Symons, D. K. (2000). Does the Conners' continuous performance
test aid in ADHD diagnosis? Journal of Abnormal Child Psychology, 28(5), 415-424.

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

103

McGough, J. J., & McCracken, J. T. (2006). Adult attention deficit hyperactivity disorder:
Moving beyond DSM-IV. The American Journal of Psychiatry, 163(10), 1673-1675.
doi:10.1176/appi.ajp.163.10.1673
Meyer, J. S., & Quenzer, L. F. (2013). Psychopharmacology: Drugs, the brain, and behavior.
Sunderland, MA: Sinauer Associates, Inc.
Michielsen, M., Comijs, H. C., Semeijn, E. J., Beekman, A. T. F., Deeg, D. J. H., & Sandra
Kooij, J. J. (2013). The comorbidity of anxiety and depressive symptoms in older adults
with attention-deficit/hyperactivity disorder: A longitudinal study. Journal of Affective
Disorders, 148(2), 220–227. doi:10.1016/j.jad.2012.11.063
Miller, C. J., Newcorn, J. H., & Halperin, J. M. (2010). Fading memories: Retrospective recall
inaccuracies in ADHD. Journal of Attention Disorders, 14(1), 7-14.
doi:10.1177/1087054709347189
Moffitt, T. E., Caspi, A., Taylor, A., Kokaua, J., Milne, B. J., Polanczyk, G., & Poulton, R.
(2010). How common are common mental disorders? Evidence that lifetime prevalence
rates are doubled by prospective versus retrospective ascertainment. Psychological
Medicine, 40(6), 899-909. doi:10.1017/s0033291709991036
Moffitt, T. E., Houts, R., Asherson, P., Belsky, D. W., Corcoran, D. L., Hammerle, M., … &
Caspi, A. (2015). Is adult ADHD a childhood-onset neurodevelopmental disorder?
Evidence from a four-decade longitudinal cohort study. The American Journal of
Psychiatry, 172(10), 967-77. doi:10.1176/appi.ajp.2015.14101266
Mordre, M., Groholt, B., Sandstad, B., & Myhre, A. M. (2012). The impact of ADHD symptoms
and global impairment in childhood on working disability in mid-adulthood: A 28-year

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

104

follow-up study using official disability pension records in a high-risk in-patient
population. BMC Psychiatry, 12, 174-183. doi: 10.1186/1471-244X-12-174
Munkvold, L. H., Manger, T., & Lundervold, A. J. (2014). Conners’ continuous performance test
(CCPT-II) in children with ADHD, ODD, or a combined ADHD/ODD diagnosis. Child
Neuropsychology, 20(1), 106-126. doi:10.1080/09297049.2012.753997
Murphy, P. (2002). Inhibitory control in adults with attention-deficit/hyperactivity disorder.
Journal of Attention Disorders, 6(1), 1-4. doi: 10.1177/108705470200600101
Murphy, K., & Barkley, R. A. (1996). Attention deficit hyperactivity disorder adults:
Comorbidities and adaptive impairments. Comprehensive Psychiatry, 37(6), 393-401.
doi:10.1016/s0010-440x(96)90022-x
Murphy, P., & Schachar, R. (2000). Use of self-ratings in the assessment of symptoms of
attention deficit hyperactivity disorder in adults. American Journal of Psychiatry, 157(7),
1156-1159. doi:10.1176/appi.ajp.157.7.1156
National Institute of Mental Health. (2010). ADHD: Signs, symptoms, research [webpage].
Retrieved from https://www.nimh.nih.gov/news/media/2010/adhd.shtml
National Institute of Mental Health. (2017). Attention-Deficit/Hyperactivity Disorder [webpage].
Retrieved from https://www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivitydisorder-adhd.shtml
Nigg, J. T. (2001). Is ADHD a disinhibitory disorder? Psychological Bulletin, 127(5), 571–598.
doi:10.1037/0033-2909.127.5.571
Nigg, J. T., Johnstone, J. M., Musser, E. D., Long, H. G., Willoughby, M. T., & Shannon, J.
(2016). Attention-deficit/hyperactivity disorder (ADHD) and being overweight/obesity:
New data and meta-analysis. Clinical Psychology Review, 43, 67-79.

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

105

doi:10.1016/j.cpr.2015.11.005
O'dougherty, M., Neuchterlein, K. H., & Drew, B. (1984). Hyperactive and hypoxic children:
Signal detection, sustained attention, and behavior. Journal of Abnormal
Psychology, 93(2), 178-191. doi:10.1037/0021-843x.93.2.178
Ogundele, M. O., Ayyash, H. F., & Banerjee, S. (2011). Role of computerized continuous
performance task tests in ADHD. Progress in Neurology and Psychiatry, 15(3), 8-13.
doi:10.1002/pnp.198
Oosterlaan, J., Logan, G. D., & Sergeant, J. A. (1998). Response inhibition in AD/HD, CD,
comorbid AD/HD+ CD, anxious, and control children: A meta-analysis of studies with
the stop task. The Journal of Child Psychology and Psychiatry and Allied
Disciplines, 39(3), 411-425. doi:10.1111/1469-7610.00336
Owens, J. S., Goldfine, M. E., Evangelista, N. M., Hoza, B., & Kaiser, N. M. (2007). A critical
review of self-perceptions and the positive illusory bias in children with ADHD. Clinical
Child and Family Psychology Review, 10(4), 335-351. doi:10.1007/s10567-007-0027-3
Owens, J. S., & Hoza, B. (2003). The role of inattention and hyperactivity/impulsivity in the
positive illusory bias. Journal of Consulting and Clinical Psychology, 71(4), 680-691.
doi:10.1037/0022-006x.71.4.680
Pauls, C. A., & Crost, N. W. (2004). Effects of faking on self-deception and impression
management scales. Personality and Individual Differences, 37(6), 1137-1151.
doi:10.1016/j.paid.2003.11.018
Pennington, B. F., & Ozonoff, S. (1996). Executive functions and developmental
psychopathology. Journal of Child Psychology and Psychiatry, 37, 51–87.
doi:10.1111/j.1469-7610.1996.tb01380.x

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

106

Peterson, S. E., & Posner, M. I. (2012). The attention system of the human brain: 20 years after.
Annual Review of Neuroscience, 35, 73-89. doi: 10.1146/annurev-neuro-062111-150525
Pliszka, S. (2005). The neuropsychopharmacology of Attention-Deficit/Hyperactivity Disorder.
Biological Psychiatry, 57, 1385-1390. doi: 10.1016/j.biopsych.2004.08.026
Posner, M. I. (1980). Orienting of attention. Quarterly Journal of Experimental Psychology, 32,
3-25. doi: 10.1080/00335558008248231
Posner, M. I., & Petersen, S. E. (1990). The attention system of the human brain. Annual Review
of Neuroscience, 13(1), 25-42. doi:10.1146/annurev.neuro.13.1.25
Prevatt, F., & Young, J. L. (2014). Recognizing and treating attention-deficit/hyperactivity
disorder in college students. Journal of College Student Psychotherapy, 28(3), 182–200.
doi:10.1080/87568225.2014.914825
Ptacek, R., Kuzelova, H., & Stefano, G. B. (2011). Dopamine D4 receptor gene DRD4 and its
association with psychiatric disorders. Medical Science Monitor, 17(9), 215–220.
doi:10.12659/msm.881925
Quay, H.C. (1988). The behavioral reward and inhibition system in childhood behavior disorder.
In L. M. Bloomingdale (Ed.), Attention deficit disorder, Vol. 3 (pp. 176–185). Oxford:
Pergamon Press.
Quinn, C. (2003). Detection of malingering in assessment of adult ADHD. Archives of Clinical
Neuropsychology, 18, 379–395. doi:10.1093/arclin/18.4.379
Rapport, M. D., Chung, K., Shore, G., & Isaacs, P. (2001). A conceptual model of child
psychopathology: Implications for understanding attention deficit hyperactivity disorder
and treatment efficacy. Journal of Clinical Child Psychology, 30, 48–58.
doi:10.1207/s15374424jccp3001_6

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

107

Reid, A. M., Graziano, P. A., Balkhi, A. M., McNamara, J. P., Cottler, L. B., Meneses, E., &
Geffken, G. R. (2015). Frequent nonprescription stimulant use and risky behaviors in
college students: The role of effortful control. Journal of American College Health,
63(1), 23-30. doi:10.1080/07448481.2014.960422
Rigler, T., Manor, I., Kalansky, A., Shorer, Z., Noyman, I., & Sadaka, Y. (2016). New DSM-5
criteria for ADHD — Does it matter? Comprehensive Psychiatry, 68, 56–59.
doi:10.1016/j.comppsych.2016.03.008
Rossi, A. F., Bichot, N. P., Desimone, R., & Ungerleider, L. G. (2007). Top-down attentional
deficits in macaques with lesions of lateral prefrontal cortex. Journal of Neuroscience,
27(42), 11306-11314. doi: 10.1523/jneurosci.2939-07.2007
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome Jr, E. D., & Beck, L. H. (1956). A
continuous performance test of brain damage. Journal of Consulting Psychology, 20(5),
343-350. doi:10.1037/h0043220
Rubia, K., Cubillo, A., Woolley, J., Brammer, M. J., & Smith, A. (2011). Disorder-specific
dysfunctions in patients with attention-deficit/hyperactivity disorder compared to patients
with obsessive-compulsive disorder during interference inhibition and attention
allocation. Human Brain Mapping, 32(4), 601-611. doi:10.1002/hbm.21048
Sandford, J. A., & Turner, A. (1995). Intermediate visual and auditory continuous performance
test interpretation manual. Richmond, VA: Braintrain.
Sandford, J. A., & Turner, A. (2004). IVA+ Plus: Integrated visual and auditory performance
test. Toronto, Canada: Brain Train.
Schachar, R. J., Chin, S., Logan, G. D., Ornstein, T. J., Crosbie, J., Ickowicz, A., & Pakulak, A.
(2004). Evidence for an error monitoring deficit in attention deficit hyperactivity

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

108

disorder. Journal of Abnormal Child Psychology, 32(3), 285–293.
doi:10.1023/b:jacp.0000026142.11217.f2
Schachar, R. J., Crosbie, J., Barr, C. L., Ornstein, T. J., Kennedy, J., Malone, M., … & Pathare,
T. (2005). Inhibition of motor responses in siblings concordant and discordant for
attention deficit hyperactivity disorder. The American Journal of Psychiatry, 162(6),
1076-1082. doi: 10.1176/appi.ajp.162.6.1076
Schachar, R. J., Logan, G. D., Robaey, P., Chen, S., Ickowicz, A., & Barr, C. (2007). Restraint
and cancellation: Multiple inhibition deficits in attention deficit hyperactivity disorder.
Journal of Abnormal Child Psychology, 35(2), 229-238. doi:10.1007/s10802-006-9075-2
Schultz, N. R., Silvestri, M. M., & Correia, C. J. (2017). Diversion of prescription stimulants
among college students: An initial investigation of injunctive norms. Addictive
Behaviors, 65, 264-268. doi:10.1016/j.addbeh.2016.08.022
Sebastian, A., Pohl, M. F., Klöppel, S., Feige, B., Lange, T., Stahl, C., ... & Tüscher, O. (2013).
Disentangling common and specific neural subprocesses of response
inhibition. Neuroimage, 64, 601-615. doi:10.1016/j.neuroimage.2012.09.020
Seidman, L., Valera, E., & Makris, N. (2005). Structural brain imaging of attentiondeficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1263-1272.
doi:10.1016/j.biopsych.2004.11.019
Sexton, C.C., Gelhorn, H. L., Bell, J. A., & Classi, P. M. (2012). The co-occurrence of reading
disorder and ADHD: Epidemiology, treatment, psychosocial impact, and economic
burden. Journal of Learning Disabilities, 45, 538-564. doi: 10.1177/0022219411407772

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

109

Shalev, L., Ben-Simon, A., Mevorach, C., Cohen, Y., & Tsal, Y. (2011). Conjunctive continuous
performance task (CCPT) – a pure measure of sustained attention. Neuropsychologia,
49(25), 84-91. doi: 10.1016/j.neuropsychologia.2011.05.006
Shaw, P., De Rossi, P., Watson, B., Wharton, A., Greenstein, D., Raznahan, A., … &
Chakravarty, M. M. (2014). Mapping the development of the basal ganglia in children
with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child
& Adolescent Psychiatry, 53(7), 780-789. doi:10.1016/j.jaac.2014.05.003
Sibley, M. H., Mitchell, J. T., & Becker, S. P. (2016). Method of adult diagnosis influences
estimated persistence of childhood ADHD: A systematic review of longitudinal studies.
The Lancet Psychiatry, 3(12), 1157–1165. doi:10.1016/s2215-0366(16)30190-0
Sibley, M. H., Pelham Jr, W. E., Molina, B. S., Gnagy, E. M., Waxmonsky, J. G., Waschbusch,
D. A., ... & Kuriyan, A. B. (2012). When diagnosing ADHD in young adults emphasize
informant reports, DSM items, and impairment. Journal of Consulting and Clinical
Psychology, 80(6), 1052-1061. doi:10.1037/a0029098
Simon, V., Czobor, P., Bálint, S., Mészáros, A., & Bitter, I. (2009). Prevalence and correlates of
adult attention-deficit hyperactivity disorder: meta-analysis. The British Journal of
Psychiatry, 194(3), 204-211. doi:10.1192/bjp.bp.107.048827
Simon, V., Czobor, P., & Bitter, I. (2013). Is ADHD severity in adults associated with the
lifetime prevalence of comorbid depressive episodes and anxiety disorders? European
Psychiatry, 28(5), 308–314. doi:10.1016/j.eurpsy.2012.05.002
Skirrow, C., & Asherson, P. (2013). Emotional lability, comorbidity and impairment in adults
with attention-deficit hyperactivity disorder. Journal of Affective Disorders, 147(1-3),
80–86. doi:10.1016/j.jad.2012.10.011

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

110

Sollman, M. J., Ranseen, J. D., & Berry, D. T. (2010). Detection of feigned ADHD in college
students. Psychological Assessment, 22(2), 325-335. doi:10.1037/a0018857
Sonuga-Barke, E. J., Sergeant, J. A., Nigg, J., & Willcutt, E. (2008). Executive dysfunction and
delay aversion in attention deficit hyperactivity disorder: Nosologic and diagnostic
implications. Child and Adolescent Psychiatric Clinics of North America, 17(2), 367-384.
doi:10.1016/j.chc.2007.11.008
Spencer, T. J., Biederman, J., & Mick, E. (2007). Attention-deficit/hyperactivity disorder:
Diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics 7(1), 73-81.
doi:10.1016/j.ambp.2006.07.006
Spencer, T. J., Biederman, J., Wilens, T. E., & Faraone, S. V. (2002). Overview and
neurobiology of attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry,
63(12), 3-9.
Stevens, M. C., Pearlson, G. D., Calhoun, V. D., & Besette, K. L. (2018). Functional
neuroimaging evidence for distinct neurobiological pathways in attentiondeficit/hyperactivity disorder. Biological Psychiatry: Cognitive Neuroscience and
Neuroimaging, 3(8), 675-685. doi: 10.1016/j.bpsc.2017.09.005
Stickley, A., Koyanagi, A., Takahashi, H., Ruchkin, V., & Kamio, Y. (2016). Attentiondeficit/hyperactivity disorder symptoms and suicide ideation and attempts: Findings from
the adult psychiatric morbidity survey 2007. Journal of Affective Disorders, 189(1), 321328. doi:10.1016/j.jad.2015.09.061
Stickley, A., Koyanagi, A., Takahashi, H., Ruchkin, V., & Kamio, Y. (2017). Attentiondeficit/hyperactivity disorder symptoms and loneliness among adults in the general

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

111

population. Research in Developmental Disabilities, 62, 115–123.
doi:10.1016/j.ridd.2017.01.007
Sullivan, B. K., May, K., & Galbally, L. (2007). Symptom exaggeration by college adults in
attention-deficit hyperactivity disorder and learning disorder assessments. Applied
Neuropsychology, 14(3), 189-207. doi:10.1080/09084280701509083
Swick, D., Ashley, V., & Turken, A. U. (2008). Left inferior frontal gyrus is critical for response
inhibition. BMC Neuroscience, 9(102), 1-11. doi: 10.1186/1471-2202-9-102
Taylor, A., Deb, S., & Unwin, G. (2011). Scales for the identification of adults with attention
deficit hyperactivity disorder (ADHD): A systematic review. Research in Developmental
Disabilities, 32(3), 924-938. doi:10.1016/j.ridd.2010.12.036
Tamana, S. K., Ezeugwu, V., Chikuma, J., Lefebvre, D. L., Azad, M. B., Moraes, T. J., … &
Mandhane, P. J. (2019). Screen-time is associated with inattention problems in
preschoolers: Results from the CHILD birth cohort study. PLoS ONE, 14(4), 1-15. doi:
10.1371/journal.pone.0213995
Teichert, T., & Ferrera, V. P. (2015). A new paradigm and computational framework to estimate
stop-signal reaction time distributions from the inhibition of complex motor sequences.
Frontiers in Computational Neuroscience, 9(87), 1-17. doi: 10.3389/fncom.2015.00087
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attentiondeficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135(4),
994-1001. doi:10.1542/peds.2014-3482
Tollander, H. (2011). The integrated visual and auditory continuous performance test: Does the
comprehension scale discriminate ADHD? (Doctoral dissertation, Pacific University).

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

112

Uno, M., Abe, J., Sawai, C., Sakaue, Y., Nishitani, A., Yasuda, Y., ... & Takeuchi, Y. (2006).
Effect of additional auditory and visual stimuli on continuous performance test (noisegenerated CPT) in AD/HD children–usefulness of noise-generated CPT. Brain and
Development, 28(3), 162-169. doi:10.1016/j.braindev.2005.06.007
Van de Mortel, T. F. (2008). Faking it: social desirability response bias in self-report
research. The Australian Journal of Advanced Nursing, 25(4), 40-48.
Van Mourik, R., Oosterlaan, J., & Sergeant, J. A. (2005). The stroop revisited: A meta-analysis
of interference control in AD/HD. Journal of Child Psychology and Psychiatry, 46(2),
150–165. doi:10.1111/j.1469-7610.2004.00345.x
van Velzen, L. S., Vriend, C., de Wit, S. J., & van den Heuvel, O. A. (2014). Response inhibition
and interference control in obsessive–compulsive spectrum disorders. Frontiers in
Human Neuroscience, 8(419), 1-22. doi:10.3389/fnhum.2014.00419
VanVoorhis, C. W., & Morgan, B. L. (2007). Understanding power and rules of thumb for
determining sample sizes. Tutorials in Quantitative Methods for Psychology, 3(2), 43-50.
doi:10.20982/tqmp.03.2.p043
Verbruggen, F., & Logan, G. D. (2008). Response inhibition in the stop-signal paradigm. Trends
in Cognitive Sciences, 12(11), 418-424. doi: 10.1016/j.tics.2008.07.005
Wakefield, J. C. (2015). DSM-5, psychiatric epidemiology and the false positives
problem. Epidemiology and Psychiatric Sciences, 24(3), 188-196.
doi:10.1017/s2045796015000116
Waldman, I. D., & Gizer, I. R. (2006). The genetics of attention deficit hyperactivity disorder.
Clinical Psychology Review, 26, 396-432. doi:10.1016/j.cpr.2006.01.007

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

113

Weinberg, W. A., & Brumback, R. A. (1992). The myth of attention deficit-hyperactivity
disorder: Symptoms resulting from multiple causes. Journal of Child Neurology, 7(4),
431-445. doi:10.1177/088307389200700420
Weiss, W. U., Weiss, P. A., Cain, S., & Manley, B. (2009). Impression management in police
officer candidacy on the MMPI-2. Journal of Police and Criminal Psychology, 24(2),
120-125. doi:10.1007/s11896-009-9044-0
Westover, A. N., & Halm, E. A. (2012). Do prescription stimulants increase the risk of adverse
cardiovascular events?: A systematic review. BMC Cardiovascular Disorders, 12(1), 4151. doi:10.1186/1471-2261-12-41
Wilens, T. E., Biederman, J., Faraone, S. V., Martelon, M., Westerberg, D., & Spencer, T. J.
(2009). Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically
referred adults with ADHD. The Journal of Clinical Psychiatry, 70(11), 1557–1562.
doi:10.4088/jcp.08m04785pur
Willcutt, E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A
meta-analytic review. Neurotherapeutics, 9(3), 490–499. doi:10.1007/s13311-012-0135-8
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005). Validity of
the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic
review. Biological psychiatry, 57(11), 1336-1346. doi:10.1016/j.biopsych.2005.02.006
Williamson, D., & Johnston, C. (2015). Gender differences in adults with attentiondeficit/hyperactivity disorder: A narrative review. Clinical Psychology Review, 40, 15–
27. doi:10.1016/j.cpr.2015.05.005

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

114

Wodushek, T. R., & Neumann, C. S. (2003). Inhibitory capacity in adults with symptoms of
attention deficit/hyperactivity disorder (ADHD). Archives of Clinical Neuropsychology,
18, 317-330. doi: 10.1016/S0887-6177(02)00152-X
Wood, D., Reimherr, F. W., Wender, P. H., & Johnson, G. E. (1976). Diagnosis and treatment of
minimal brain dysfunction in adults. Archives of General Psychiatry, 33(12), 1453-1453.
doi:10.1001/archpsyc.1976.01770120057005
Wright, L., Lipszyc, J., Dupuis, A., Thayapararajah, S. W., & Schachar, R. (2014). Response
inhibition and psychopathology: A meta-analysis of go/no-go task performance. Journal
of Abnormal Psychology, 123(2), 429-439. doi:10.1037/a0036295
Young, J. L., & Goodman, D. W. (2016). Adult attention-deficit/hyperactivity disorder
diagnosis, management, and treatment in the DSM-5 era. The Primary Care Companion
for CNS Disorders, 18(6), 1-18. doi:10.4088/pcc.16r02000
Young, J. T., Carruthers, S., Kaye, S., Allsop, S., Gilsenan, J., Degenhardt, L., … Preen, D.
(2015). Comorbid attention deficit hyperactivity disorder and substance use disorder
complexity and chronicity in treatment-seeking adults. Drug and Alcohol Review, 34(6),
683–693. doi:10.1111/dar.12249
Zetterqvist, J., Asherson, P., Halldner, L., Långström, N., & Larsson, H. (2013). Stimulant and
non-stimulant attention deficit/hyperactivity disorder drug use: Total population study of
trends and discontinuation patterns 2006–2009. Acta Psychiatrica Scandinavica, 128(1),
70-77. doi:10.1111/acps.12004
Zhao, X., Page, T. F., Altszuler, A. R., Pelham III, W. E., Kipp, H., Gnagy, E. M., … & Pelham,
Jr., W. E. (2019). Family burden of raising a child with ADHD. Journal of Abnormal
Child Psychology, 1-12. doi: 10.1007/s10802-019-00518-5

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

115

Ziobrowski, H., Brewerton, T. D., & Duncan, A. E. (2018). Associations between ADHD and
eating disorders in relation to comorbid psychiatric disorders in a nationally
representative sample. Psychiatry Research, 260, 53–59.
doi:10.1016/j.psychres.2017.11.026

ASSOCIATIONS BETWEEN THE ASRS AND TDIA

116

APPENDICES
Appendix A: Informational Cover Letter – Form A
Dear Participant,
My name is Ben Darling and I am a doctoral candidate in Counseling Psychology at West
Virginia University (WVU). I kindly request your participation in a research study titled:
“Associations between the Adult ADHD Self-Report Rating Scale and the Test of Differential
Inhibition and Attention.” The primary aim of this study is to assess the validity of a newly
developed measure of attentional processing and response control in adulthood. The study
involves completing a basic demographics questionnaire, one self-report survey of attention and
hyperactivity/impulsivity, and one computerized continuous performance test.
This project has been acknowledged by the Institutional Review Board at WVU and is being
conducted under the guidance of Dr. Monica Leppma, Associate Professor. Your participation is
completely voluntary and you may withdraw from the study at any time without penalty. Your
involvement will be kept as confidential as legally possible and no identifying information will
be collected. You will have the option of providing your email address to enter an anonymous,
random drawing to win one of ten $10 Amazon gift cards. This information will be kept separate
from your individual responses to the survey questions.
Your participation in this study is highly valued and will require no more than 35 minutes of
your time. This study will be conducted on WVU’s Evansdale Campus at a designated time and
location. Please send an email to abdarling@mix.wvu.edu for more information on how to
participate in this study.
Thank you for your consideration. Please do not hesitate to contact Ben Darling
(abdarling@mix.wvu.edu) or Dr. Monica Leppma (monica.leppma@mail.wvu.edu) should you
have questions or need additional information.
Sincerely,
Ben Darling, M.A.
Counseling Psychology Doctoral Candidate
Department of Counseling, Rehabilitation
Counseling, and Counseling Psychology
West Virginia University | Morgantown, WV
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Appendix B: Informational Cover Letter – Form B
Dear Participant,
My name is Ben Darling and I am a doctoral candidate in Counseling Psychology at West
Virginia University (WVU). I kindly request your participation in a research study titled:
“Associations between the Adult ADHD Self-Report Rating Scale and the Test of Differential
Inhibition and Attention.” The primary aim of this study is to assess the validity of a newly
developed measure of attentional processing and response control in adulthood. The study
involves completing a basic demographics questionnaire, one self-report survey of attention and
hyperactivity/impulsivity, and one computerized continuous performance test.
This project has been acknowledged by the Institutional Review Board at WVU and is being
conducted under the guidance of Dr. Monica Leppma, Associate Professor. Your participation is
completely voluntary and you may withdraw from the study at any time without penalty. Your
involvement will be kept as confidential as legally possible and no identifying information will
be collected.
Your participation in this study is highly valued and will require no more than 35 minutes of
your time. As a thank you, you will be provided with one $10 Amazon gift card for participating
in this study. This study will be conducted in the MindFit Clinic at the WVU Carruth Center for
Psychological and Psychiatric Services (MindFit) by trained personnel. Please contact your
MindFit representative if you have questions or need additional information about this study.
Thank you for your consideration. Please do not hesitate to contact Ben Darling
(abdarling@mix.wvu.edu) or Dr. Monica Leppma (monica.leppma@mail.wvu.edu) should you
have questions or need additional information.
Sincerely,
Ben Darling, M.A.
Counseling Psychology Doctoral Candidate
Department of Counseling, Rehabilitation
Counseling, and Counseling Psychology
West Virginia University | Morgantown, WV
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Appendix C: Informed Consent

Only Minimal Risk
Consent Information Form
(without HIPAA)
Principal Investigator

Monica

Leppma, Ph.D.
Department
Counseling, Rehabilitation Counseling, and Counseling Psychology
Protocol Number
1901443696
Study Title
Associations between the Adult ADHD Self-Report Rating Scale (ASRS) and
the Test of Differential Inhibition and Attention (TDIA)
Co-Investigator(s)
Ben Darling, M.A.
Sponsor (if any)
N/A

Contact Persons
In the event you experience any side effects or injury related to this research, you should contact the Carruth
Center for Psychological and Psychiatric Services at (304) 293-4431. If you have any questions, concerns, or
complaints about this research, you can contact Dr. Monica Leppma at (304) 293-0540.
For information regarding your rights as a research subject, to discuss problems, concerns, or suggestions
related to the research, to obtain information or offer input about the research, contact the Office of Research
Integrity and Compliance at (304) 293-7073.

Introduction
You, _______________, have been asked to participate in this research study, which has been explained to you
by _______________. This study is being conducted by Ben Darling, M.A. and Monica Leppma, Ph.D., in the
Department of Counseling, Rehabilitation Counseling, and Counseling Psychology at West Virginia University.

Purpose(s) of the Study
The purpose of this study is to examine the relationship between scores on a self-report measure of adult ADHD
symptomatology and CPT performance to aid in the validation of a newly developed computerized assessment
of ADHD symptoms. The primary aim is to determine whether SSRT may distinguish between individuals
with self-reported impairment from ADHD symptoms and those who report no such impairment on a CPT with
greater central processing demands.

Description of Procedures
This study involves analysis of self-report and objective measures of attentional processing and response
control. Participation in this study will take approximately 30 minutes. You do not have to answer every
question. You are being invited to allow your anonymous scores to be included in the analyses.

Discomforts
There are no known or expected risks from participating in this study, except for the mild frustration associated
with answering the questions. Should you experience any form or degree of distress related to your participation
in this study, resources are available at the WVU Carruth Center for Psychological and Psychiatric Services
(304-293-4431), WVU Quin Curtis Center (304-293-1824), and WVU Student Health Center (855-WVUCARE).

Alternatives
You do not have to participate in this study.
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Benefits
You may not receive any direct benefit from this study. The knowledge gained from this study may eventually
benefit others.

Financial Considerations
There are no special fees for participating in this study.

Confidentiality
Any information about you that is obtained through your participation in this research will be kept as
confidential as legally possible. Your research records and test results, just like hospital records, may be
subpoenaed by court order or may be inspected by the study sponsor or federal regulatory authorities (including
the FDA if applicable) without your additional consent.
In any publications that result from this research, neither your name nor any information from which you might
be identified will be published without your consent.

Voluntary Participation
Participation in this study is voluntary. You are free to withdraw your consent to participate in this study at any
time.
Refusal to participate or withdrawal will not affect your class standing or grades, as appropriate, and will
involve no penalty to you. Refusal to participate or withdrawal will not affect your future care, or your
employee status, as appropriate, at West Virginia University.
In the event new information becomes available that may affect your willingness to participate in this
study, this information will be given to you so that you can make an informed decision about whether or
not to continue your participation.
You have been given the opportunity to ask questions about the research, and you have received answers
concerning areas you did not understand.
Upon signing this form, you will receive a copy.
I willingly consent to participate in this research.

______________________________________________________________________________
Printed Name
Signature
Date
Time
The participant has had the opportunity to have questions addressed. The participant willingly
agrees to be in the study.
Signature of Investigator or Co-Investigator
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Signature
Date
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Appendix D: Demographics Questionnaire
Please complete the following information.
Item

Text

Answers
_______

Type

1

Age:

Text
Entry

2

Sex:

o Male
o Female
o Self-Identify: _______

Multiple
Choice

3

Have you ever been clinically diagnosed
with Attention-Deficit Hyperactivity
Disorder?

o Yes
o No

Multiple
Choice

4

If you answered “Yes” on Item 3, how
old were you (in years) when you were
diagnosed? If you answered “No” on
Item 3, proceed to Item 5.

o Between 0 and 12
years
o Between 12 and 18
years
o 18 or older

Multiple
Choice

5

Which of the following best describes
you?

o Currently prescribed
psychostimulant
medication
o Previously prescribed
psychostimulant
medication, but not
currently
o Never prescribed
psychostimulant
medication

Multiple
Choice
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Appendix E: Adult ADHD Self-Report Scale (ASRS-V1.1) Symptom Checklist
Please answer the questions below, rating yourself on each of the criteria shown using the scale
provided. Please select the answer that best describes how you have felt and conducted yourself
over the past 6 months.
1. How often do you have trouble wrapping up the final details of a project, once the challenging
parts have been done?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
2. How often do you have difficulty getting things in order when you have to do a task that requires
organization?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
3. How often do you have problems remembering appointments or obligations?
Never
Rarely
Sometimes
Often
0
1
2
3

Very Often
4

4. When you have a task that requires a lot of thought, how often do you avoid or delay getting
started?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
5. How often do you fidget or squirm with your hands or feet when you have to sit down for a long
time?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
6. How often do you feel overly active and compelled to do things, like you were driven by a
motor?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
7. How often do you make careless mistakes when you have to work on a boring or difficult
project?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
8. How often do you have difficulty keeping your attention when you are doing boring repetitive
work?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
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9. How often do you have difficulty concetrating on what people say to you, even when they are
speaking to you directly?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
10. How often do you misplace or have difficulty finding things at home or at work?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
11. How often are you distracted by activity or noise around you?
Never
Rarely
Sometimes
0
1
2

Often
3

Very Often
4

12. How often do you leave your seat in meetings or other situations in which you are expected to
remain seated?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
13. How often do you feel restless or fidgety?
Never
Rarely
Sometimes
0
1
2

Often
3

Very Often
4

14. How often do you have difficulty unwinding and relaxing when you have time to yourself?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
15. How often do you find yourself talking too much when you are in social situations?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
16. When you’re in conversation, how often do you find yourself finishing the sentences of the
people you’re talking to, before they can finish them themselves?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
17. How often do you have difficulty waiting your turn in situations when turn-taking is required?
Never
Rarely
Sometimes
Often
Very Often
0
1
2
3
4
18. How often do you interrupt others when they are busy?
Never
Rarely
Sometimes
0
1
2

Often
3

Very Often
4
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Appendix F: Closing Statement and Resources
Thank you for your participation!
If you are currently experiencing any form or level of distress, and wish to seek professional
assistance, mental health services are available at the following locations:
Carruth Center for Psychological and Psychiatric Services | West Virginia University
http://well.wvu.edu/ccpps
(304)293-4431
Quin Curtis Center | West Virginia University
https://psychology.wvu.edu/about/quin-curtis-center
(304) 293-1824
Student Health Center | West Virginia University
https://wvumedicine.org/ruby-memorial-hospital/services/wvu-specialty-clinics/student-health/
(855) WVU-CARE
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